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ABSTRACT
Proteins bind to DNA to form switches and circuits that control the flow of genetic
information from DNA sequence to the physical components of cells and organisms. The
dynamic performance of genetic switches depends on the coupling of the common processes of
transcription and translation to protein-specific folding, assembly and binding reactions. For
many model circuits protein dimerization and DNA binding are fast relative to the time scale of
transcription and translation and thus amenable to modeling by statistical thermodynamics. In
these cases, the distribution of proteins between monomers and dimers and between nonspecific
and specific DNA complexes can be simply predicted from the measured free energy of each of
the states.
Lambda Cro is unusual. Dimers of Cro are required to recognize operator DNA and
repress transcription, but dimerization is weak compared to DNA binding and slow relative to
other processes required for its production and function. Dimerization limits both the equilibrium
extent and the kinetic rate of operator binding in vitro. To test the hypothesis that these unusual
dimerization characteristics are critical to Cro‟s regulatory function in living cells, “single-chain
dimer” variants of Cro (scCro) that eliminate the slow dimerization step have been characterized.
Fluorophore-conjugated, single-cysteine Cro variants have been used to facilitate the
investigations of the equilibria and kinetics of DNA binding by fluorescence resonance energy
transfer (FRET). Single-chain Cro dimer binds to operator DNA more than 100-fold faster and
tighter than wild type Cro. A secondary mutation (scCro(PFPS-AWSG)) that replaces two proline
ii

residues in the context of scCro reduces its equilibrium affinity for operator DNA to a level
similar to wild type Cro but binds at a similar rate to scCro
Extrapolation from test-tube to cellular conditions is complicated both by differences in
solution conditions and by additional complexity of the intracellular environment. The factor
most likely to affect DNA binding in each case is the cellular ionic environment and the presence
of a million-fold excess of non-specific DNA binding sites that cumulatively compete with the
operator site for Cro binding. To address these differences DNA binding studies as a function of
salt and added nonspecific DNA have been undertaken. Kinetic and equilibrium studies of
complex formation have been completed by direct FRET measurements and by competition
studies with unlabeled proteins and DNA. Specificity ratios obtained for lambda OR3 versus nonspecific DNA range from 103 to 106, depending on the Cro variants and the salt concentration.
Although the scCro and scCroPFPS-AWSG have similar salt dependences for operator binding,
scCroPFPS-AWSG has a significantly higher salt dependence for nonspecific binding. These results
will provide inputs for mathematical models of the dynamics and equilibrium extent of
repression by Cro variants in living cells.
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CHAPTER 1
INTRODUCTION

1

1.1 INTRODUCTION
The regulation of gene expression relies on multiple processes, like protein assembly,
protein-DNA binding and cooperativity. Measurement of the physical chemical properties of
these regulatory events provides the necessary information from which conceptual, predictive
models can be developed to translate the molecular interaction properties into the “whole
system” physiology (Ackers et al., 1982; Alberts, 1998). The lambda genetic switch has been
an important paradigm for the modeling of genetic regulatory networks. Cro is one of the two
primary regulators along with lambda repressor (CI) of the lambda switch. The Cro
polypeptide contains 66 amino acids. Cro has been studied genetically, biochemically and
structurally. The mechanism of Cro repression is fundamental to understanding gene
regulation in bacteriophage lambda.
The decision whether to replicate and finally lyse its bacterial host cell or repress viral
gene expression and integrate into the host chromosome to form a lysogen is due to the
competition between Cro and CI. Like many bacterial repressors Cro binds to DNA as a dimer
(Brennan et al.,1986; Jana et al., 1997).The assembly of Cro dimers is relatively slow and
weak (Satumba and Mossing 2002). The lysogenic state is stable unless it is perturbed by the
DNA-damage response of the host when degradation of CI leads to switching to the lytic state.
In absence of the DNA-damage response, escape from lysogeny is less than 10-8 /cell
generation (Little & Michalowski, 2010). The ultimate stability of the lysogenic state may
depend critically on the slow assembly of Cro monomers to yield active Cro dimer. A
significant delay between the production of Cro monomers and the assembly of active Cro
dimers will lower the probability for escape from the lysogenic state.
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In many models of transcriptional regulation both the protein-DNA binding reactions
and the protein dimerization reactions are rapid on the time scale of RNA transcription and
protein translation and thus simply modeled as equilibrium processes. The assembly of Cro
dimers is however very slow (Satumba and Mossing 2002) which is unusual for site-specific
DNA binding proteins. The slow Cro dimerization is important for the detailed gene
expression response curves, and especially for the rare switching events that determine
lysogen stabilities. Previous studies have shown that folding and assembly of the lambda Cro
repressor from the denatured states were limited by proline isomerization. Limitation to DNA
binding due to slow dimerization can be overcome in single-chain Cro (scCro) which no
longer need to dimerize. We have built scCro variants that will allow us to separate kinetic
from thermodynamic effects.
Extrapolation from „in vitro‟ to „in vivo‟ (test tube to cellular) conditions is complicated
both by differences in solution conditions and by additional complexity of the intracellular
environment. The factor most likely to affect DNA binding in each case is the cellular ionic
environment and the presence of a million-fold excess of non-specific DNA binding sites that
cumulatively compete with the operator site for Cro binding.
Most protein-DNA interactions exhibit substantial polyelectrolyte effects (Record
1998). Depending on the distribution of charges on the protein and the coupled assembly
reactions, net cations release from the DNA can be partially compensated by net anions
release from the protein. The thermodynamic driving force associated with ion release
depends on the bulk ion concentration. The net number of ions released can be estimated from
the log / log slope of Kd vs [K+].
3

Both specific and non-specific protein DNA interactions are salt dependent. So in order
to make a reasonable extrapolation from in vitro conditions to in vivo, one needs estimates not
just for the relative binding affinity and the number of non-specific sites. One also needs to
know the relative salt dependence.
This dissertation will characterize the biophysical properties of these scCro variants in
anticipation of their incorporations into model control circuits.
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1.2 DISSERTATION OUTLINE
Chapter 1 introduces the background that forms the basis for our studies. The lambda
genetics is used as a prototypic example of transcriptional regulation conferred by linked
protein–protein and protein–DNA interactions. Cro, one of the two primary regulators of the
lambda switch, competes with CI to determine the fate of a host cell by interaction with operator
sites. The structures of Cro and some Cro variants are described. Cro repressor-DNA interactions
were expressed by thermodynamic models.
Chapter 2 describes the constructions of scCro variants. Several scCro variants were
constructed and purified. The mutations were confirmed by DNA sequencing and protein
expression. These scCro variants were then labeled with 5-iodoacetamidofluorescein (5-IAF) at
the single cysteine residue to facilitate the investigations of the equilibria and kinetics of DNA
binding by fluorescence resonance energy transfer (FRET).
Chapter 3 describes FRET studies of operator DNA binding by scCro variants. Kinetic
and equilibrium studies have been completed by direct FRET measurements and by competition
studies. scCro variant (scCroPFPS-AWSG) has near wild type Cro binding affinity but associates and
dissociates hundreds of times faster.
Chapter 4 describes DNA binding studies of scCro variants-nonspecific DNA (nsDNA)
interactions and salt effects on scCro variants-specific DNA interactions. Competition
experiments were performed by addition excess of the unlabeled nsDNA to protein-DNA
complex. The binding affinity of specific interaction is 100-fold over nsDNA interaction for wild
type Cro but 10000-fold for scCro variants. Dependences of association rate constants,
5

dissociation rate constants and equilibrium constants on [K+] were investigated. From the plots
of the logarithm of Kd as a function of the logarithm of [K+] we can conclude that scCro
variants-specific DNA interactions, as well as wild type Cro, have shown moderate dependences
on salt concentration.
Salt effects on nonspecific interactions were also investigated. Compared to the effect of
salt on specific binding, nonspecific DNA interactions show drastically different salt sensitivity.

1.3 PROTEINS AND GENE EXPRESSION
Proteins are the principle actors in living organisms. They are products of the expression
of genes encoding the genetic information in the organism's genetic material (DNA or RNA).
Genes are sequences of DNA that encode RNAs and determine the structure of macro-molecules
that constitute the machinery of living cells. At any given time, each cell transcribes only a
subset of its genes into RNA to direct production of other molecules. Transcription is the first
step leading to gene expression. During transcription an enzyme known as RNA polymerase use
the sequence along one of double stranded DNA as a template to synthesize a linear molecule
called messenger RNAs (mRNAs). Messenger RNAs are decoded by the ribosome to construct a
specific amino acid chain, or polypeptide, the primary structure of proteins. The linear
polypeptide chains will later fold into an active protein. In bacteria, as the 5‟ end of the mRNA is
accessible the process of translation begins even though the transcription is not completed yet.
Proteins are well known as enzymes. Almost all the biochemical reactions in the cell are
catalyzed by one or more enzymes. The chief characteristic of proteins is their ability to bind
6

other molecules specifically and tightly. The cells are able to reproduce, to sense, and to respond
to the environment due to a complex network of interactions between protein and other
molecules. However, Proteins are produced in the different quantity at different time. The
expression of proteins is regulated and stimulated by internal and environmental factors and
finally is tuned up or down in response to metabolic demands. It is very important to understand
the mechanisms responsible for the control of genes and the circuits created by many linked
genes. Regulatory networks were first studied in bacteria and bacterial viruses. One of the most
simple and wildly studied regulatory systems is lambda genetic switch which allow researchers
to derive the basic mechanism of gene expression and provided a paradigm for the understanding
of gene expression in higher organisms.

1.4 BACTERIOPHAGE LAMBDA GENETIC SWITCH
Genes are sequences of DNA that encode RNAs and determine the structure of macromolecules that constitute the machinery of living cells. At any given time, each cell transcribes
only a subset of its genes into RNA to direct production of other molecules. Genes that are
actually being transcribed into RNA are “on” and those not expressed are “off”.
Transcription initiation is highly regulated by the binding of special proteins to specific
sites on the DNA. A negative regulator prevents transcription, and a positive regulator stimulates
transcription of a gene. It is very important to understand the mechanisms responsible for the
control of genes and the circuits created by many linked genes. The lambda genetic switch is one
of the simplest and most widely studied systems. Substantial genetic and structural information is
7

available. The lambda switch has been used for years to derive the basic mechanisms of gene
expression at increasing levels of sophistication and provides a paradigm for the understanding
of gene expression in higher organisms (Ptashne and Gann 2002; Ptashne 2004).
The Lambda virion is a particle consisting of a head, containing double-stranded linear
DNA molecule in an icosahedral protein coat and a tail with fibers. The phage particle is
infectious: it recognizes and binds to its host, E. coli, causing DNA in the head of the phage to be
ejected through the tail fibers into the cytoplasm of the bacterial cell, while leaving its coat
behind.
There are two fates awaiting λ-infected bacterium. Usually, a “lytic cycle” ensues, where
the lambda DNA is extensively replicated and the genes for head, tail and lysis proteins are
expressed. New phage particles are formed within the bacterium, and some 45 minutes following
infection the bacterium lyses and releases about 100 progeny phage. However, in some cells the
phage DNA may integrate itself into the host cell chromosome. In this lysogenic state, the λ
DNA is called a prophage and remains dormant at a specific site within the host‟s genome
without apparent harm to the host. As the bacterium grows and divides, the prophage is passively
replicated and confers immunity to the cell against infection by another lambda phage. Once
established, the lysogenic state is extremely stable. However, this state can switch to the lytic
state by a pathway called prophage induction (right streamlined diagram in Figure 1.1), which
operates through the host SOS response (Little and Mount 1982; Ptashne 2004). DNA damage
prompts RecA, a protein ordinarily involved in facilitating recombination between DNA
molecules, to become a special kind of protease, which facilitates self-cleavage by  repressor,
thereby triggering expression of lytic genes and induction (Little 1984)
8

Figure 1.1: Alternative life cycles of bacteriophage lambda
As an obligate parasite, bacteriophage  must inject its DNA into the bacterium to
multiply. Upon infection, the phage has two mechanisms of action: In the lytic pathway (left
streamlined diagram in Figure 1.1), the cell executes a pattern of viral gene expression,
replicates the viral DNA, makes around 100 new virions in about 45 minutes, and finally lyses.
In the lysogenic pathway (right streamlined diagram in Figure 1.1), the viral DNA is physically
integrated into the host genome where it is replicated when the host divides. Once established,
the lysogenic state is extremely stable. However, this state can switch to the lytic state by a
pathway called prophage induction (red arrows) by host SOS response. DNA damage results in
activation of the host RecA protein which will stimulate the self-cleavage of CI, leading to its
inactivation. The phage chromosome abandons its previously useful scheme of passive
replication and enters the lytic pathway.

9
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1.4.1 Phage lambda lysis–lysogeny decision circuit
The lambda genetic switch that determines whether a phage reproduces and lyses the cell
or whether it integrates into its host genome to become a prophage was among the first genetic
switch to be studied and the system has contributed immensely to our present understanding of
developmental pathways (Ptashne, Jeffrey et al., 1980). This well understood circuitry involves
several interesting regulatory behaviors.
The patterns of gene expression during lambda growth are summarized in Figure 1.2.
There are three primary phases in the life cycle of phage λ (Ptashne 2004), very early, early,
and late. The first two transcriptional patterns set the stages for the decision to lyse or lysogenize.
In the very early stage, phage lambda has only three moderate or strong promoters, PL, PR and
PR’, that are recognized by the host RNA polymerase. Transcription from PL causes expression of
the anti-terminator protein, N. Transcription from PR causes expression of the anti-repressor
protein, Cro. These transcribing RNA polymerase molecules stop just at the end of N and cro
genes, respectively. Transcription from PR′ pauses after a short distance and no protein is
expressed. In the early stage, N, works as a positive regulator (anti-terminator), turning on genes
to the left of N including cIII and the recombination genes and genes to the right of Cro
including cII, and the DNA replication genes – O and P, and Q. At this point the pathway
bifurcates, CII and CIII favor lysogenic growth; O and P are required for phage replication; and,
Q, another anti-terminator protein like N, favors lytic growth by helping late lytic gene
expression.
The lysis-lysogeny decision is made in the late stage based on the relative activities of
two competing regulatory proteins, CI ( repressor) and Cro (Johnson, Poteete et al., 1981). If CI
11

dominates, then lambda will go lysogenic; however if Cro dominates, then lambda will go lytic.
In the lytic growth pathway, the genes for lysis and for production of heads and tails are
expressed. The anti-terminator protein, Q, is required for expression of these genes. At the same
time, Cro first binds OR3 to prevent further synthesis of repressor from PRM and then binds to OL
to turn off the transcription initiated by PL. After sufficient Q has accumulated to activate
production of protein coats that wrap up the newly synthesized DNA molecules, the cell is lysed.
If the phage follows the lysogenic growth pathway, CII product will turn on cI and int. Int is a
site specific recombinase that integrates the phage chromosome into the host chromosome. cI
binds to OL and OR to turn on the transcription of its own gene as it turn off all the other phage
genes. In summary, Cro is one of the first protein transcripts of λ DNA within ~ 5 seconds, while
lambda repressor requires three sequential cycles of transcription and a minimum of 12 + 50 +
14 seconds for the sequential production of N, cIII and cI.
The decision between lysis and lysogeny comes down to the winner of the competition
between Cro and CI for binding to the operators OL and OR (Figure 1.3) (Herskowitz and
Hagen 1980). Both CI and Cro specifically bind the left and right operators (OL) and (OR). The
key to the battle between Cro and CI is CII. If CII activity is high, then CI will be synthesized at
high levels, binding of CI to the right operator (OR) will dominate over Cro, and lambda will go
lysogenic (Kobiler, Rokney et al., 2005). The activity of CII depends on environmental
conditions, the nutritional state of the host cell and multiplicity of infection. If the bacterial host
is growing under rich conditions (plenty of nutrients), then  is more likely to go lytic (Kihara et
al., 1997). Under poorer growth conditions or the multiplicity of infection (ratio of phage to host
cells) is high (5 – 10 phages per infected cell), cII builds up to higher levels and stimulates the
12

production of cI and the establishment of lysogeny (Kourilsky and Knapp 1974; Herkowitz and
Hagen 1980). In order to regulate the lysis-lysogeny decision as described above, it is critical
that Cro does not dominate the regulation of OR before the cascade of events leading to cI
production. The activity of the Cro repressor relative to cI must be delayed.

13

Figure 1.2 Patterns of lambda gene expression
The genes shown in colors are on at each of the indicated stages of growth. The products
of gene expression in each stage, according to the functions of the proteins they encode, are
shown in different colors. Genes of related function are turned on and off together. These
coordinately regulated genes lie in contiguous blocks except at the late lysogenic expression
where only two genes, cI and int, are active.

14
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Figure 1.3: Phage lambda lysis-lysogeny decision circuit
Genes of the phage λ genome are shown in the colored boxes. Promoters are showed as
arrowheads, transcripts as colored lines above or below the genes. Arrows in genes indicate the
direction of transcription.
The early transcripts for pL and pR promoters are shown as red arrows. The late
transcript from pR‟ is indicated with black arrows. The CII-activated pI, pRE, and pAQ
transcripts are indicated with purple arrows. The pRM transcript activated by CI is a green arrow.
The operators OL and OR where CI and Cro bind are shown next to the pL and pR promoters.
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1.5 CRO REPRESSOR
Cro, a regulatory protein of the lambdoid family of bacteriophages (Campbell 1994; Hall
et al., 2011), works in opposition to the phage's repressor to control the genetic switch that
determines whether lytic or lysogenic cycle will follow infection. Lambda Cro is relatively
small, only 66 amino acids folded into three α-helical regions and three β-strands. Cro functions
as a homodimer by binding to the two operator half sites (Hsiang, Cole et al., 1977; Roberts,
Shimatake et al., 1977).

1.5.1 Wild type Cro
The three dimensional structure of wild type Cro has been determined by X-Ray
crystallography and Nuclear Magnetic Resonance (NMR) (Anderson, Ohlendorf et al., 1981;
Matsuo, Shirakawa et al., 1995; Albright, Mossing et al., 1996; Albright, Mossing et al., 1998).
Wild type Cro forms a stable homodimer of 66-residue subunits. Each subunit contains three α helixes and three β sheets: β1(residues 3-6), α1(residues 7-14), α2 (residues 16-23), α3 (residues
27-35), β2(residues 40-45), β3(residues 49-56) (Anderson et al., 1981) (Figure 1.4). Gly15
connects directly from helix α1 to helix α2 (Douglas H. Ohlendorf et al., 1981). Two of these α –
helixes (α2 and α3) are separated by a short turn and are held at 550 with respect to one
another. α3, the recognition helix, fits into the major groove of the operator DNA. The β3 β3‟
antiparallel β-strands (residues 54-56 and 54„- 56„) forms the most part of the dimer
interface. The primary interface between monomers is a series of hydrogen bonds between
residues A52, E54, K56, and F58 of each monomer. Main-chain hydrogen bonds occur between
18

N54 and O56, O54 and N56, N56 and O56, and O56 and N56 respectively. The surface areaof
the interface is 1280 Å2, or 640 Å2 per half-dimer (Albright et al., 1996). Phe-58 from one
monomer inserts into a hydrophobic pocket in the other monomer, forming a “ball-and-socket”
interaction and is responsible for 180Å2 of a total of 640 Å2 of accessible surface buried in the
dimer interface (Albright, Mossing et al., 1996). Phe 58 is at the apex of a sharp bend from
which it extends into the hydrophobic core (Albright, Mossing et al., 1996) which is enclosed by
Leu 7, Leu 23, Val 25, Ala 29, Ile 30, Ala 33, Ile 40, Leu 42, Ala 52, and Pro 59 and is covered
by Arg 38 and Glu 54, which form a salt bridge. The tip of the aromatic ring points toward the
center of the recognition helix (R3) near the main chain between Ala 29 and Ile 30.
Peptide bonds in proteins in the majority of cases exist in the trans configuration
(Ramachandran and Sasisekharan, 1968). In the native Cro dimer, the K56 – P57 peptide bond is
in the trans configuration while the F58 – P59 is cis. The K56-K57 peptide bond is expected to
remain predominantly in the native trans configuration and 77% of the F58-P59 peptide is
expected to convert from cis to trans. Interconversion of the cis and trans configurations of the
peptide bonds that precede proline residues is a slow process (Fischer et al., 1984). Slow phases
in protein folding have been attributed to proline isomerization (Schmid 1982; Schreiber and
Fersht 1993; Aronsson et al., 1997; Kamen and Woody, 2002; Wedemeyer et al., 2002).
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Figure 1.4 Structure of lambda Cro repressor
Ribbon diagram shows the wild-type (wt) Cro dimer structure (Ohlendorf, Tronrud et al.,
1998) (5cro.pdb). Only the first 61 residues are visible in the crystal structure. Some residues
side chains in one subunit and residue 58 are shown as ball-and-stick model. There are three α–
helices and three β–sheets in each subunit of Cro, which are shown in different colors. The
primary and secondary structures of Cro are also illustrated. The shading of the bars below the
sequence represents the solvent accessible surface area for each residue. The figure was drawn
with the program Molscript (Kraulis 1991).
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1.5.2 Cro variants
For many model circuits, protein dimerization and DNA binding are fast relative to the
time scale of transcription and translation and thus amenable to modeling by statistical
thermodynamics (Gray Ackers, Madeline Shea, 1981). Lambda Cro is unusual. Cro dimerization
is weak compared to DNA binding and slow relative to other processes required for its
production and function. Weak dimerization limits both the equilibrium extent and the kinetic
rate of operator binding. Previous studies showed that the slow dimer assembly from the
unfolded state is complicated because of the competing monomeric forms and proline
isomerization (Satumba, W. J. & Mossing, M. C. (2002).).
scCro dimers were constructed by connecting the N-terminus of one subunit with the Cterminus of next by a polypeptide linker (AGTGGSGG) (Jana, R; 1998). scCro eliminates the
slow dimerization step and binds to DNA hundreds of times faster and more strongly than wtCro.
Refolding of scCro however is slow. Rates are similar to the proline isomerization limited rates
observed in the dimer and engineered monomer. In the native dimer, two prolines (57 and 59)
locate at F58‟s flanks. The K56-P57 peptide bond is in the trans configuration while the F58-P59
bond is cis. The interconversion of the cis and trans configuration of the peptide bonds upon
dimerization is a slow process (Fischer et al., 1984). From previous work we know P57 and F58
have been successfully replaced in the dimer context (Pakula et al., 1986; Mossing and Sauer
1990). Subsequent studies showed that residue 58 could also be replaced by the third aromatic
residue, tryptophan. The substitutions of P59 that will enable protein to still fold, dimerize and
ultimately bind to DNA is a big challenge. As the simplest of the naturally occurring 20 amino
acids, with a single hydrogen atom in its side chain glycine is a good candidate amino acid the
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most flexibility to replace this proline. Any perturbation of the amino acid sequence of a protein
can affect that protein„s stability and interaction with DNA. Proline replacement was designed to
trade off some DNA binding affinity for a faster rate in single chain proteins to create a protein
that both assembles rapidly and binds tightly.
This design may also enable us to isolate kinetic from equilibrium effects. Our studies
showed that scCro without one set of prolines (scCro(PFPS-AWSG)) binds operator DNA hundreds
times faster than wild type Cro but with a close binding affinity to wild type Cro. scCro(PFPS-AWSG))
allows us to isolate the effects of kinetics and assess whether thermodynamic models are
sufficient to describe simple Cro regulatory circuits.

1.5.3 Cro-DNA interactions
Protein-DNA interactions play a key role in vital processes such as gene regulation. The
developmental decision for phage  either to lysogenize or to lyse its host cell has been
classically described as a competition between Cro and the lambda repressor cI (Johnson, Poteete
et al., 1981). Anderson et al., 1981 reported that Cro uses a helix-turn-helix motif in binding
DNA and since then this motif has been found to play a similar role in other DNA binding
proteins (Kolkhof et al., 1992; Roy et al., 2002; Shearwin et al., 2002). Cro dimer binds the two
operator half sites, with the recognition helix of each monomer (α3) inserted into the DNA's
major groove. The α3 recognition helices are oriented with their axes parallel to the major
groove. The side chains of each helix are thus positioned to interact with the edges of base pairs
on the floor of the groove. Cro can bind to six sequence-specific sites, each of which is a slightly
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different 17-bp DNA segment with approximate twofold sequence symmetry (Maniatis et al.,
1975). Cro binds to the three sites in OR with binding affinity order of OR3>OR2=OR1 and to the
three sites in OL with binding affinity order of OL1>OL2=OL3. Previous studies showed that Cro
binding to OR3 plays a critical role in blocking the transcription of PR. Cro functions as a
homodimer. Cro must fold, dimerize quickly enough and then bind operator sites to repress the
transcription of cI genes and win the competition. ScCro constructed by connecting the cterminal of one subunit and N-terminal of the next one showed hundreds times faster operator
DNA binding rate and affinity (Jana and Mossing, 1998). This is further evidence that
dimerization is weak and limits DNA binding of Cro. In the absence of DNA Cro has been
shown to be mostly monomeric. Dissociation constants have been reported in the 10-6 M (Jana et
al., 1997) and 10-7 M range (Darling et al., 2000). An important question that is addressed in this
thesis is that slow assembly of Cro play an important role in regulation of the lambda switch.
Protein and nucleic acid interact via complementarity of molecular surfaces. Although
direct interactions between atoms in the respective macromolecular partners can be listed and
analyzed, water and small-molecule co-solutes can often provide the bulk of the driving force for
the interaction (Record, Zhang and Anderson 1998). The dominant non-covalent forces for
macromolecular interaction are the hydrophobic effect and polyelectrolyte effect. DNA is a
polyelectrolyte. The high charge density of phosphodiester backbone results in condensation of
counterions to neutralize the bulk of the charge on the phosphates. In solution of monovalent
salts at neutral pH DNA phosphates each entrap ~ 0.88 counterions in the local environment. In
this sense DNA behaves like a nearly undissociated salt. The polyelectrolyte effect arises from
tightly bound counter-ions that are displaced during the formation of macromoecular complex.
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Fundamentally there is a parallelism between the hydrophobic effect and polyelectrolyte effect.
Self-association of nonpolar groups releases water; binding of an oligocation to a polyelectrolyte
release electrolyte ions. Consequently both of these processes are exchange reactions (Record et
al., 1978). Because protein-DNA interactions are multiple equilibria involving many solution
components, Kobs are critically dependent on the concentration of electrolyte and buffer ions
present. In chapter IV the competition of Cro variants DNA interactions from small ions will be
described.
1.6 STATISTICAL THERMODYNAMIC MODELS TO DESCRIBE GENE CIRCUITS
1.6.1 Thermodynamic model
Genetic switches are composed of regulatory proteins and their cognate DNA binding
sites. To understand the performance of a genetic switch, it is important to obtain detailed
knowledge about the physical and chemical properties of the system (Alberts, 1998). For most
proteins, the dimerization and DNA binding are fast relative to the time scale of transcription and
translation and thus amenable to modeling by statistical thermodynamics. A model based on
statistical thermodynamics is sufficient to account for some of the known physiological
properties of the repressor-operator regulatory system (Ackers, 1982). In such models, the
distribution of proteins between monomers and dimers and between nonspecific and specific
DNA complexes can be simply predicted from the measured free energy of each of the states.
Takeda et al., (1989) have reported the effects of systematic base substitutions upon the
free energy of Cro-DNA associations. Based on the assumption that occupancy of operator sites
by repressor dimers and the resulting effects on gene transcription are determined by equilibrium
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statistical thermodynamic probabilities, each operator configuration can be ascribed an exact
expression of its probability as a function of repressor concentration and free energy (related to
binding affinity). Quantitative expressions that describe Cro dimer binding at individual operator
sites are constructed by considering the relative probability, fs, of each operator configuration
(Ackers et al., 1982)
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Table 1-1: Microscopic configurations and free energies for the operator-Cro
system OR

Species

Configuration

Free energy
contributions

Free
energy(∆Gs),kcal

S

OR3

OR2

OR1

1

0

0

0

Reference state

0

2

0

0

C

ΔG1

-10.8

3

0

C

0

ΔG2

-10.8

4

C

0

0

ΔG3

-12.1

5

0

C

C

ΔG1+ΔG2+ΔG12

-21.6

6

C

0

C

ΔG1+ΔG3+ΔG13

-22.9

7

C

C

0

ΔG2+ΔG3+ΔG23

-22.9

8

C

C

C

ΔG1+ΔG2+ΔG3+ΔG123

-33.7

The probability fs for binding the system in one state:
(
∑

⁄
(

)[
⁄ )[

]
]

Where R is the gas constant, T is the absolute temperature. [cro2] is the concentration of unbound
Cro repressor dimers, and j is the number of Cro repressor dimers bound to an operator in the s
configuration (e.g. 0, 1, 2, or 3). The summation of s is taken from 0 through 8. The probability,
fs, is the fractional contribution of the microstate free energies (△Gs) to that of the overall
population (Ʃ△Gs) at a particular protein concentration. Occupancy of sites OR1 and OR2 by cro
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contributes to PR repression, while occupancy of OR3 contributes to repression at PRM. Once the
probabilities for each of the operator states are known, the binding of repressor to each operator
site in the full cooperative system can be described. For example, the total occupancy of OR3 is
given by:

The activities of the two OR-controlled promoters (PR and PRM) as a function of repressor
concentration will be quantitatively predicted, and these predictions can then be compared with
known physiological properties of the system. These parameters were then used to predict the in
vivo behavior of the system.
1.6.2 Predicted behavior of Cro and scCro bound to operator DNA
Since Cro binds DNA as a dimer, but exists mostly as a monomer in solution, the overall
reaction can be written as two coupled reactions: the first a dimerization reaction of identical Cro
monomers and the second the dimer-DNA binding reaction. The two reactions written as
dissociations are:
⇔

[ ][ ]
[ ]

⇔

[

][ ]
[
]

C is the active monomeric form of Cro repressor
C2 is the active dimeric form of Cro repressor.
O is operator DNA.
Kd1 is the equilibrium dimer dissociation constant.
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(

)

(

)

Kd2 is the equilibrium DNA-complex dissociation constant.
At equilibrium both reactions are governed by dissociation constants: Kd1 and Kd2. Kd1
has been measured by a variety of methods (Jana 1997, Jia 2005) as has the composite.
The fraction of the operator sites occupied by Cro dimer can be
Ө = C2 / (C2+Kd2)

(1–3)

Substituting (C2/Kd1) for C2 in equation (3), we get
Ө = C2 / (C2+ Kd1 Kd2)

(1–4)

We can estimate Kd2-the dimer-DNA dissociation constant from Kd1 and the midpoint of
the operator titration and we get Kd2=10-12M.
Several scCro dimers have been constructed. In these proteins dimerization is no longer a
required precursor to DNA binding. As observed operator binding affinity of scCro repressor is
hundreds of times higher than wtCro. Although effectively decoupling dimerization and its slow
kinetics from DNA binding, the very large increase affinity makes it hard to compare scCro to
wtCro. In this work we examined the DNA binding characteristics of scCro variant which is
expected to have a similar binding affinity and a similar saturation profile.
Although the end products of Cro-DNA complex and scCro-DNA complex are similar,
the composite binding reaction for wtCro is second order in Cro while the scCro reaction is first
order in protein.

29

CHAPTER II
CONSTRUCTIONS OF CRO VARIANTS
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2.1 INTRODUCTION
Cro dimers undergo dissociation into subunits at micromolar concentration range that are
far in excess of those required for DNA binding (Jana, 1997). The observed dimer dissociation
constant ((7 ±4) × 10-6 M) dictates that at a total Cro subunit concentration of 1× 10-9 M only two
subunits in 7000 will form dimers at equilibrium. These rare dimers must therefore bind to DNA
with very high affinity. The predicted large pool of free subunits and very limited population of
free assembled dimers also suggests that dimer assembly might be a kinetically limiting process
in Cro dimer-DNA association (Mossing, 1997). scCro plasmids were constructed by connecting
the N-terminus of one subunit and C-terminus of the next one with a polypeptide (Jana et al.,
1997). Studies of equilibrium and kinetic DNA binding by scCro were completed by gel shift
assay (Jana et al., 1997). The engineered Cro dimer shows dramatically higher binding affinity
and faster kinetics without slow dimer assembly.
Ideally we would like to construct a Cro dimer in which nothing was changed except the
ability of its subunits to dissociate from each other. If dimer dissociation could be prevented,
while leaving the structure and function of the protein unperturbed, the concentration of protein
required for saturation of an operator site should reveal the intrinsic dimer affinity. Refolding of
scCro dimers however is slow. Rates are similar to the proline isomerization limited rates
observed in the dimer and engineered monomer.
In the native dimer, two prolines (57 and 59) flank F58. The K56-P57 peptide bond is in
the trans configuration while the F58-P59 bond is cis. The interconversion of the cis and trans
configuration of the peptide bonds upon dimerization is a slow process. Proline replacement was
designed to trade off some DNA binding affinity for a faster rate in single chain proteins so that
31

we can create a protein with a close binding affinity and similar saturation profile to wtCro.
Prolines 57 and 59 were replaced in combinatorial mutagenesis experiments by Satumba (2003
dissertation). Previous mutagenesis studies identified several functional replacements for
residues 57 and 58 (Pakula et al., 1986; Mossing and Sauer 1990) but no functional replacement
had been identified for Pro 59 and Ser 60 the residues involved in the only cis-peptide bond in
the native Cro structure. To allow for additional flexibility in the polypeptide backbone in the
region of the 58-59 peptide bonds a glycine was allowed as a substitute for serine 60. In one
limited randomization scheme P57 and F58 were replaced Alanine and Tryptophan and P59, and
S60 was replaced with Glycine or Serine (with equal probability). The mutagenesis scheme can
be denoted P57A F58W P59 (G/S) S60(G/S). In a second experiment codons 57-60 were
replaced combinatorial oligonucleotides designed to allow for a possible hydrophobic residue at
position 59, P57A F58WP59(I/V/T/A/S/G) S60(G/S). Proline replacement variants were
identified in the context both of the 66 residue wild-type polypeptide and 140 residue scCro8
variant.
Single cysteine variants of Cro were constructed by (Jia et al., 2005) to identify surface
exposed positions in the protein where fluorophores could be conjugated with minimal effects on
protein structure, stability dimer assembly or DNA binding. Among the cysteine variants that
best met those criteria is N-terminally extended protein that adds a His-6 purification tag and a
unique cysteine residue to the unstructured N-terminus of Cro. For this work we also chose the
single cysteine in a Histidine Tag (N-C3-(H)6): MGCS(H)6SSGL) at the unstructured N terminus.
Thus a fluorophore was labeled on this cysteine to investigate the characteristics of Cro variantsDNA interactions by FRET.
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2.2 MATERIALS AND METHODS
2.2.1 Buffers and reagents
KP20 buffer contains 20 mM potassium phosphate, 1 mM EDTA, and 1.4 mM 2mercaptoethanol (βME), 100 μg/ml of bovine serum albumin (BSA, ordered from Sigma), 5%
(v/v) glycerol for protein stability and fluorescence signal measurements at pH 7.0; KP200 buffer
is KP20 plus 200 mM potassium chloride. All experiments were carried out in KP200 buffer
unless otherwise indicated. Urea lysis buffer contains 50mM Tris.HCl, 100mM NaCl, 6M urea,
10%sucrose and1.4mM βME. SDS loading buffer contains 2% SDS, 12% glycerol, 0.4 M tris
base (pH 8.45), 0.00125% bromophenol blue, and 0.73 M βME. Restriction endonucleases (Ndel
and Bgll) and DNA-modifying enzymes were obtained from New England Biolabs, Promega,
Fisher, Stratagene, and Invitrogen. 5-iodoacetamidofluorescein (IAF) was purchased from
Molecular Probes. Tetramethylrhodamine labeled OR3R and OR3F were purchased from IDT.
B-PERTM Bacterial Protein Extraction Reagent was purchased from PIERCE. SP SepharoseTM
Fast Flow resin was ordered from Amersham Biosciences. Restriction enzymes were obtained
from NEB and Promega. The 46 bp hairpin oligonucleotide (OR3HP) with the sequence of OR3
(5– TTTAT CCCTT GCGGT GATAA ATTTT TTTAT CACCG CAAGG GATAA A –3) was
purchased from Trilink Biotech.
JM109 (DE3) and BL21 (DE3) cells were obtained from laboratory stocks. The pET()33b-N-His-C3Cro (Jia et al., 2005), pET(-)33b-N-His-smCro (Satumba‟s thesis, 2003).
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2.3 CONSTRUCTION OF NHIS-C3-SINGLE-CHAIN CRO VARIANT
2.3.1 Plasmids Purification, Digestion and Ligation
Single colonies of JM109 (DE3), bearing pET(-)33b plasmid, were obtained by streaking
cells from glycerol freezer laboratory stocks on LB agar plates containing 50 μg/ml kanamycin
(Kan) and grown overnight at 37 °C. 50 ml of culture medium (LB + 50 μg/ml Kan; LB/Kan)
was inoculated with a single bacterial colony in 250 ml flask and grown overnight at 37 °C with
vigorous shaking. The bacterial culture was pelleted by centrifugation. The StrataPrep® EF
Plasmid Midiprep Kit (Stratagene) was used to purify the plasmid DNA. About 20 μg plasmid
DNA was obtained from 50 ml of culture medium. The purified DNA was eluted with Tris⋅HCl
buffer (10 Mm Tris base, adjust the Ph to 8.5 with HCl) and stored at 4 °C.
A single-chain Cro variant that lacks one set of prolines at 57-59 (Nhis-C3-scCroPFPSAWSG)

was constructed from Nhis-C3-scCro and N-His-scCroPFPS-AWSG. These genes were

expressed from the plasmids consisting of PET(-)33b N-His-C3-Cro and PET(-)33b N-HisscCroPFPS-AWSG vectors respectively in which the single-chain Cro genes were cloned between the
NdeI and XhoI sites. Two restriction endonucleases, Ndel and Bgll, were used to cut the circular
plasmids into two linear fragments. The digestion was carried out by incubating 1 units of
enzyme per µg of DNA in Promega‟s buffer II at 370C for overnight. The reaction was then
stopped by adding an excess amount of EDTA, which chelates the Mg++ required for enzymatic
activity. DNA fragments from the reactions were separated on a 0.8% agarose gel, visualized by
SYBR® Green staining and excised from gel.
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DNA fragments were purified from agarose gel following the QIAEXII Agarose Gel
extraction protocol. The purified DNA fragment Nhis-C3 was then annealed with scCroPFPS-AWSG
fragment with T4 DNA ligase at 160C overnight. The ligation results were checked by agarose
gel.
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Figure 2.1: pET(-)33b(+) H6-C3- scCroPFPS-AWSG plasmid and protein sequence
2.1a. The pET(-)33b H6-C3- scCroPFPS-AWSG plasmid has 5179 base pairs which was
constructed by inserting the Ndel to Bgl1 fragment of pET(-)33b(+) H6-C3-Cro (including H6C3) into the Ndel to Bgl1 fragment of pET(-)33b(+) H6-scCro(PFPS-AWSG) (including scCroPFPSAWSG.

H6-C3 is coded between Ncol and Ndel. scCroPFPS-AWSG is coded between Ndel and XhoI.

Some special restriction sites around cro gene are also shown. The figure is drawn with the
program PlasMapper Version 2.0 (http://wishart.biology.ualberta.ca/PlasMapper/).
2.1b. indicates the sequences of H6-C3-scCroPFPS-AWSG gene, protein, and restriction sites
on the fragment.
b1 shows the sequence of the subunit of scCroPFPS-AWSG where the prolines were replaced.
The black box shows the fragment including the residues of H6-C3 where the fluorophore was
attached on the single cysteine (showed as a green star). The red box shows the proline
replacement residues in one Cro subunit (upper are the residues of wtCro and lower are proline
replacement residues). The blue box shows the polypeptides linker connecting two Cro subunits.
b2 shows the sequence of the wild-type subunit of scCroPFPS-AWSG. The green box shows
the proline residues.
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2.1a
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2.1b NHis-C3-scCroPFP-AWG gene, protein sequence and restriction sites
b1. Prolines replaced subunit of scCroPFPS-AWSG
M G C* S
H
H
H
H
H H
S
S
G
L H
ATG GGC TGC AGC CAT CAT CAT CAT CAT CAC AGC AGC GGC CTG CAT
NcoI
Fluorophore attachment and His Tag
M1 E
Q
R
I
T
L
K D Y10 A M R
F
G
ATG GAA CAA CGC ATA ACT TTA AAA GAT TAT GCA ATG CGC TTT GGC
NdeI
DraI
Bal I
Q
T
K T A20 K21 D L G
V Y Q
S
A I30
CAA ACC AAG ACA GCT AAA GAT CTC GGC GTG TAT CAA AGC GCG ATC
BglII
N
K A
I
H
A G
R
K I40 F41 L
T
I
N
AAC AAG GCC ATC CAT GCC GGC CGA AAA ATA TTT TTG ACT ATA AAC
P
F
P
S
CCC TTC CCG AGT
A D
G S V50 Y A
E
E
V K
A
W
S
G
GCT GAT GGA TCC GTA TAC GCG GAA GAG GTA AAG GCC TGG AGC GGC
scCroPFPS-AWSG
N K
K T
T A66 A G T
G
G
S
G
G
AAC AAA AAA ACA ACA GCG GCC GGT ACC GGT GGC TCT GGC GGC
Peptide Linker

b2. Wild type subunit of scCroPFP-AWG
M
E
Q
R
I
T
L
K
D Y A M R
F G
ATG GAA CAA CGC ATA ACT TTA AAA GAT TAT GCA ATG CGC TTT GGC
DraI
Bal I
Q
T
K T
A K D
L
G
V Y Q
S
A
I
CAA ACC AAG ACA GCT AAA GAT CTC GGC GTG TAT CAA AGC GCG ATC
BglII
N
K
A
I
H
A G
R
K
I
F L
T
I
N
AAC AAG GCC ATC CAT GCC GGC CGA AAA ATA TTT TTG ACT ATA AAC
A D
G
S
V Y A
E
E
V K
P
F
P
S
GCT GAT GGA TCC GTA TAC GCG GAA GAG GTA AAG CCC TTC CCG AGT
N K
K T
T
A
AAC AAA AAA ACA ACA GCA
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2.4 CONFIRMATION OF H6-C3 CYSTEINE
2.4.1 Screen clones for expression.
Sixteen single colonies were picked from the transformation plate of the constructed
Nhis-C3-scCroPFP-AWG. The candidates were restreaked and inoculated into 1.5ml of liquid
culture medium (LB/Kan). After overnight growth at 37 °C, 20 l of the culture was inoculated
into fresh 3.8 ml of LB/Kan and grown in a rolling drum at 37 °C for 2 hours. Then 1ml was
transferred to a new tube and the left 3mls was used to produce protein by addition of IPTG to a
final concentration of 1mM. Cultures were incubated for another two hours. Bacterial cells were
pelleted by centrifugation at 13,000 rpm for 100 seconds. The cells were lysed and crude protein
mixtures were extracted with B-PERTM Bacterial Protein Extraction Reagent. The lysate was
mixed with 100 l resin pre-equilibrated with KP20 buffer and was spun at 5,000 rpm for 2
minutes to pellet the protein-contained resin. The pellet was then washed twice with KP20 buffer.
50 l KP20 with 1 M NaCl was used to elute the Cro proteins. To identify proteins containing
cysteine residues, 20l of the eluted samples were labeled with 1mM 5-IAF (Jia 2005) and
verified by running a 20% Tris-tricine gel (Schagger and Von Jagow 1987). The gel was soaked
in water for 15 minutes to remove the excess dye and then photographed by UV
transillumination. The gel was then stained for about 1 hour with Coomassie Brilliant Blue and
destained overnight using a solution of methanol and acetic acid. If the Nhis-C3-mutation is
successful, the bright band for the dye-labeled Cro when the picture was taken under UV and the
blue band of Cro protein after the procedure of stain/destain can be seen. Six or more of the
sixteen single colonies have passed the test for each of Nhis-C3- scCroPFPS-AWSG.
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2.4.2 DNA Sequencing
The candidates that pass the protein assay then were subjected to DNA sequencing to
confirm the mutations. The plasmids for all the candidates were purified with the StrataPrep® EF
Plasmid Midiprep Kit. The purified DNA was eluted with TrisHCl buffer (pH 8.5, 10mM).
DNA sequencing experiments were done by using a Beckman Coulter kit (CEQ™ DTCS Quick
Start Kit, P/N 608120) and the CEQTM 2000 Dye Terminator Cycle Sequencing protocol.
Experiments were performed on a CEQTM 8000 Beckman Coulter instrument according to the
manual. DNA sequencing results confirm the sequence of the constructs (sequence showed in
Figure 2.1b).
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2.4.3 Quantify expression level on SDS page gel
Single colonies were inoculated into 1 ml of LB/Kan. After overnight growth at 37 °C, 10
l of the culture was inoculated into fresh 2 ml of LB/ Kan and grown for three hours. Then 1 ml
of culture was taken out (saved as IPTG-) and the rest was induced with 1mM IPTG (IPTG+)
and grown for additional two hours. The cells induced and uninduced were both harvested by
spinning at 13,000 rpm in a microcentrifuge for 40 seconds. The supernatant was removed and
the pellet was suspended with 200 l SDS loading buffer. The SDS/cell pellet mixtures were
heated at 95 °C for 5 minutes and then cooled and spun again to pellet nucleic acids and cell
walls. 10 l of the supernatant was loaded onto a Tris-tricine gel. The gel was first run at 100 V
for 10 minutes and then 200 V for 40 minutes, stained for about one hour with Coomassie
Brilliant Blue and destained using a solution of methanol and acetic acid. All of the variants
express the proteins at similar levels. Figure 2.2 shows that scCro(PFPS-AWSG) is expressed at a
high level and therefore it is likely to be stably folded.
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Figure 2.2 Expression levels and final purity of scCro variants
The SDS-PAGE gel shows induced expression level of scCroPFPS-AWSG and scCro. Lanes1
is pure wild type Cro as a marker. Lane 2-5 contain alternating uninduced and induced lysates of
JM109(DE3) cells expressing scCroPFPS-AWSG and scCro as indicated. Lanes 6-7 contain purified
scCro and scCroPFPS-AWSG as indicated.
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2.4.4 Protein Expression, Purification and Labeling
Nhis-C3- scCroPFPS-AWSG was expressed in JM109 (DE3) cells under the control of T7
promoter. For protein expression, cells were grown with aeration at 37 °C in LB broth plus
kanamycin (30µg/mL) to an OD600 ≈1. IPTG was added to a final concentration of 1 mM. The
cultures were allowed to grow for 3 h at 37oC after induction. The cells were chilled to 4°C and
harvested by centrifugation at 3000g.
For initial characterization, each of the single-chain dimers were purified from 20 mL
cultures. Cells were resuspended in 1 mL of urea lysis buffer, lysed by sonication, and cleared by
centrifugation. Supernatant containing unadsorbed scCro repressor was applied to a cation
exchange chromatography on a 1 mL HiTrap SP FF column (Pharmacia) and eluted in a gradient
of 0-1 M KCl. Peak fractions (>80% pure) were used directly for fluorescein labeling and FRET
experiments.
Cro mutants containing the cysteine mutation are labeled with fluorescent dyes in order
to examine kinetics and equilibrium using fluorescence spectroscopy. The unique cysteine
residues were modified with fluorescent dyes. 50 M protein was mixed with 1 mM TCEP to
reduce the cysteine side chain. This mixture was directly incubated with 1 mM 5iodoacetomidofluorescein (5-IAF) (stored in DMF from Molecular Probes) for two hours in the
dark at room temperature. The reaction was halted by adding a ten-fold excess of dithiothreitol
(DTT), and the bulk of the unreacted dye was removed by dialysis against 20 mM potassium
phosphate buffer overnight. The labeled protein was purified away from the remaining unreacted
dye by cation exchange chromatography on a Hitrap SP sepharose (Pharmacia). Labeling
efficiency was evaluated by comparing the absorbance of the protein at 280 nm to the
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absorbance of the 5- IAF at 490nm. These concentrations are confirmed by Bradford assay
(Bradford 1976). Concentration of the dye in the purified protein fractions were calculated using
490 of 61,000 M-1cm-1 (molar absorption coefficient, pH 7) for5-IAF.

The protein

concentrations for purified labeled proteins were determined either from the residual absorbance
at 280 nm after subtracting out the dye contribution or by a Bradford assay (Bradford 1976). All
fluorescence measurements were made on a Spex Fluoromax 3 (JY Horiba) instrument, in
photon counting mode with an internal reference and a thermostatted sample holder.
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CHAPTER III

FRET STUDIES OF CRO VARIANT – DNA COMPLEXES: KINETICS
AND EQUILIBRIUM
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3.1 FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET)

FRET is the radiationless transmission of energy from a donor molecule to an acceptor
molecule without emission of light. The donor is the dye that initially absorbs the energy, and the
acceptor is the chromophore to which the energy is subsequently transferred (Van Der Meer,
Coker et al., 1994). When they are dissociated, the donor emission is detected upon the donor
excitation. When the donor and acceptor are in proximity (1–10 nm) due to the interaction of the
two molecules, the acceptor emission is predominantly observed because of the intermolecular
FRET from the donor to the acceptor. The sensitivity of fluorescence allows studies to be carried
out at nanomolar or lower concentrations, which both minimizes the needed quantity of
biomolecules and problems associated with aggregation and low solubility (Eftink 1998). FRET
is highly efficient within the Förster radius (Ro) of the donor/acceptor pair (which is usually in
the 50 – 60 Å range), making it useful over distances encountered within many biological
macromolecules.
FRET is a useful tool to investigate macromolecular interactions in general, and
specifically protein-DNA interactions, for example. In studies with protein-DNA interactions,
the fluorophores on proteins can be either intrinsic (tryptophan, tyrosine residues, coenzymes) or
extrinsic (attached dansyl, fluorescein, pyrene) probes which can be covalently attached to either
primary amino or thiol groups on the proteins. The thiol groups, which are present in cysteine
residues in proteins, can conjugate to thiol reactive probes. Most of our fluorescence experiments
are performed with the aid of the mutant proteins containing a cysteine residue. Once the
fluorophores labeled protein and DNA are mixed, following excitation, energy can dissipate
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from a donor dye to neighboring acceptor molecules. Nearby heterocyclic ring structure, as are
present when the dye is conjugated to a nucleic acid or protein, will absorb some of this energy
and quench the dye.
Here we used 5-IAF (donor) to label the thiol groups of the cysteine residue in our FRET
studies. Tetramethylrhodamine (acceptor) labeled DNA works as an acceptor. As one of the most
commonly used donor/acceptor pair, the advantage of using IAF (donor)/tetramethylrhodamine
(acceptor) is fluorescein‟s high extinction coefficient (81,000 M-1cm-1 at pH 9 and 61,000 M1

cm-1 at pH 7). The Ro for tetramethylrhodamine and IAF pair is 55 Å. Figure 3.1 shows the

spectra of 5-IAF labeled protein and tetramethylrhodamine labeled OR3.
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Figure 3.1 Fluorescence spectra of labeled protein and DNA

Panel A shows the Excitation (dashed lines) and emission (solid lines) spectra of of 5IAF labeled Cro variants (green), rhodamine labeled OR3 (red). Same concentration (5nM) of
dye labeled protein and OR3 were excited at their maximal absorbance for emission spectra or
emitted at their maximal emission for excitation spectra. Fixed wavelengths for emission and
excitation scans were 490 nm and 520 nm for Cro variants-5-IAF 555 nm and 585 nm for OR3rhodamine respectively. The spectra were normalized to the same scale.

Panel B is the energy transfer spectra (from a typical experiment) after excitation at 490
nm, resulting in a decrease in donor (5-IAF), and an increase in acceptor (rhodamine)
fluorescence. Emission spectra of separate samples 3nM Cro-5-IAF (solid blue line), 3nM OR3rhodamine (solid red line) and the complex (Cro-OR3, solid green line) are shown. Or3rhodamine has no contribution to the fluorescence at 520nm with excitation at 490nm. Emission
spectra of equimolar equilibrium mixture of 5-IAF and rhodamine labeled OR3 is shown as a
solid green line.

49

50

51

3.2 MATERIALS AND METHODS

All experiments were carried out in KP200 buffer (20 mM potassium phosphate, 1 mM
EDTA, and 1.4 mM 2-mercaptoethanol (βME), 100 μg/ml of bovine serum albumin (BSA,
ordered from Sigma), 5% (v/v) glycerol, 200 mM potassium chloride at pH 7.0). Rhodamine
labeled OR3R (3‟ TAMRA) and OR3F were purchased from integrated DNA technologies.
Double strand OR3 was produced by hybridization of OR3R and OR3F. The 46 bp hairpin
oligonucleotide (OR3HP) with the sequence of OR3 (5– TTTAT CCCTT GCGGT GATAA
ATTTT TTTAT CACCG CAAGG GATAA A –3) was purchased from Trilink Biotech.
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Table 3.1: Sequence of oligonucleotides

Residue

Sequence of Oligos

OR3R

5‟-TTTATCACCGCAAGGGATAAA/36-TAMSp/-3‟

OR3F

5‟-TTTATCCCTTGCGGTGATAAA-3‟
5– TTTAT CCCTT GCGGT GATAA ATTTT TTTAT

OR3HP
CACCG CAAGG GATAA A –3
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Figure 3.2 Diagrams of OR3 and OR3HP

OR3R was labeled with tetramethylrhodamine at 3‟ (red color in figure).
The 46 bp hairpin oligonucleotide (OR3HP) has the sequence of OR3. The complementary parts
of the hairpin oligonucleotide were annealed with a temperature thermocycler by decreasing 1 °C
per minute (1 cycle) from 95 °C to 4 °C in the buffer containing 10 mM Tris, 1mM EDTA, and
50 mM NaCl (pH 8.0).

54

3.2.1 Kinetics Studies of Cro Variants- operator DNA Interactions
3.2.1.1

Association

rate

constants

(ka)

of

Cro

variants-operator

DNA

interactions
The decay of the fluorescence was monitored less than 1 second following the mixing of
two reagents (scCro and OR3). Proteins and operator DNA were mixed by stopped-flow to
measure the rate constant of the rapid reactions in solution (KP200 binding buffer).
1nM Fluorescein-labeled Cro-variants were mixed with at least 10 fold amount of
rhodamine-labeled operator DNA (OR3). Cro variant-DNA complexes were detected by energy
transfer from fluorescein to rhodamine. The decrease in donor fluorescence was monitored after
stopped-flow mixing. The reactions were treated as pseudo first order reactions and the
association rate constants were obtained by fitting the curve to a single exponential function
simulation in matlab.
The rate constants were also measured as second order reactions by mixing same amount
(much larger than Kd) of 5-IAF labeled scCro variants and rhodamine labeled operator NDA.
The reaction can be expressed as below:
As scCro variant and operator DNA are same amount, they disappear at the same rate and
both are written as “A” in the equations.
(3.1)
The rate of reaction, r, is given by
[ ]

Integrated the rate equation get
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[ ]

(3.2)

[

[ ]

]
[ ]

(

)

The total fluorescence (Ft) can be expressed as
[ ]

([

]

[ ])

(3.4)

Fmax is the fluorescence from scCro variant
Fmin is the fluorescence from scCro variant-operator DNA complex
The data were fit to equation (3.4) simulation in matlab (script “fitwl.m; second.m;
seconddecreas.m” showed in Appendix c).
Figure 3.3a and Figure 3.3b show the typical measurements of the ka of scCro binding to OR3
and scCroPFPS-AWSG binding to OR3.
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3.2.1.2

Dissociation

rate

constants

(kd)

of

Cro

variants-operator

DNA

interactions
The dissociation rate constants of Cro variant–OR3 interactions were measured by
fluorescence with manual or stopped-flow mixing. After 1nM of fluorescein-labeled Cro variants
and same amount of rhodamine-labeled OR3 were mixed in the solution and equilibrated, 100
fold excess of unlabeled OR3HP was added to the mixture to trap free Cro molecules. The
kinetics of the irreversible dissociation process was monitored by fluorescence and the curve was
fit to a single exponential function simulation in matlab (scripts “fitu.m; increase.m; singleex.m”
showed in Appendix c). The average kd from 6 repeats including error estimates are given either
in the text or in the tables as shown later.
Figure 3.4a and Figure 3.4b show the measurements of the kd of scCro binding to OR3
and scCroPFPS-AWSG binding to OR3.
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3.2.2 Equilibrium analysis of Cro variants-operator DNA interactions
3.2.2.1

Direct Titration Experiments of scCroPFP-AWG variant-DNA binding

1nM fluoroscein labeled scCroPFP-AWG was titrated with rhodamine-labeled OR3 from
0 to 30nM. Along with the formation of OR3-scCroPFP-AWG complex, FRET occurs. The
decay of fluorescence at 520nm (Figure 3.1) was monitored by fluorometer. The
experiments were repeated for 3 times. The average equilibrium constant (Kd = 1.2x10-9M,
shown in Figure 3.5) was obtained by fitting the data to equation (5-7) (shown in appendix
A) with Matlab (script “FF.m and CroDNAkdfit.m” shown in appendix c).
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3.2.2.2

Competition Experiments (scCroPFPS-AWSG)

Equilibrium competition experiments have been used to determine the operator DNA
binding affinity of scCroPFPS-AWSG dimer relative to scCro dimer. A small amount of high
concentration of unlabeled scCroPFPS-AWSG dimer was titrated into the mixture of equimolar preequilibrated scCro-DNA complex. The increase of fluorescence intensity of scCro, when it was
released from operator DNA by the competitive binding of engineered scCroPFPS-AWSG dimer,
was monitored by excitation at 490 nm and emission 520 nm against the total concentration of
engineered monomer. The experiments were repeated 3 times.
Equilibrium dissociation constant (Kd = 0.9 x10-9M, showed in Figure 3.6) of scCroPFPSAWSG

binding to OR3 can be obtained by fitting data to equation (5-14) with matlab script

(smkdfit.m and Ff.m showed in appendix A)

59

3.2.2.3

Competition Experiments to obtain Kd of wtCro binding to OR3

A small amount of high concentration of unlabeled wtCro(Q3C) was titrated into the
mixture of equimolar (the concentrations for both are 3nM) pre-equilibrated scCro-DNA
complex. The increase of fluorescence intensity of scCro, when it was released from operator
DNA by the competitive binding of wtCro, was monitored by excitation at 490 nm and emission
520 nm against the total concentration of Q3C. The experiment stopped when the intensity of
fluorescence did not change after three more titrations. The experiments were repeated for 3
times.
The equilibrium dissociation constant of wild type Cro-operator DNA interaction can be
estimated by the equation Kwt-obs = K1 K2 (shown in appendix A).
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3.3 RESULTS
3.3.1 scCro variants bind OR3 hundreds times faster than wild type Cro
All experiments were carried out in KP200 buffer at 25oC.
Figure 3.3 shows the association rate constants of scCro and scCroPFPS-AWSG binding to
operator DNA (OR3). scCro variants eliminate the slow assembly process and show hundreds of
times faster association (ka = (2.12 0.93) x 108 M-1s-1 for scCro and (7.8 0.9) x 108 M-1s-1 for
scCroPFPS-AWSG) with operator DNA (OR3) than wild type Cro.
Figure 3.4: Dissociation rate constants of scCro variants binding to operator DNA (OR3).
ScCro without one set of prolines dissociate hundreds of times faster than wild type Cro
and scCro. (kd = 0.00582 s-1 for scCro and 1.13 s-1 for scCroPFPS-AWSG)
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Figure 3.3: Association rate constants of scCro variants binding to operator DNA
(OR3)

Figures show the kinetic traces from typical experiments.
Panel A: Association kinetics of scCro binding to operator DNA (OR3).
The continuous lines represent theoretical fitting curves generated by fitting data to a single
exponential equation and yield association rate constant ka = (2.12 ± 0.93) x 108 M-1s-1. The
value is the average of the results of 6 experiments.

Panel B: Association kinetics of scCroPFPS-AWSG binding to operator DNA (OR3).
The continuous lines represent theoretical fitting curves generated by fitting data to a single
exponential equation and yield association rate constant
ka = (7.8 ± 0.9) x 108 M-1s-1. The value is the average of the results of 6 experiments.
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Figure 3.4: Dissociation rate constants of scCro variants binding to operator DNA
(OR3)
Figures show the kinetic traces from typical experiments.
Panel A: Dissociation kinetics of scCro binding to operator DNA (OR3).
The continuous lines represent theoretical fitting curves generated by fitting data to a single
exponential equation and yield association rate constant kd = (6.1 ± 0.62) x 10-3 s-1.
The value is the average of the results of 6 experiments.

Panel B: Dissociation kinetics of scCroPFPS-AWSG binding to operator DNA (OR3).
The continuous lines represent theoretical fitting curves generated by fitting data to a single
exponential equation and yield association rate constant kd = (1.06 ± 0.11) s-1.
The value is the average of the results of 6 experiment
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3.3.2 A single-chain Cro has near wild type Cro binding affinity
Two methods, direct titration of 5-IAF labeled scCro variants with rhodamine labeled
OR3 (OR3-R) and competition experiments, were used to measure the equilibrium dissociation
constant of scCroPFPS-AWSG operator DNA interactions. All experiments were carried out in
KP200 binding buffer at 250C. Similar equilibrium dissociation constants (Kd ≈ 1nM), which is
close to the binding affinity of wild type Cro to operator DNA (OR3), were obtained. Figure 3.5
and Figure 3.6 showed the equilibrium dissociation constant (Kd) of scCroPFPS-AWSG binding
operator DNA (OR3) by direct titration and competition method respectively.
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Figure 3.5 Equilibrium dissociation constant (Kd) of scCroPFP-AWG binding to
operator DNA (OR3) by direct titration
Figure shows the fit of Kd from a typical experiment.
Fluorescence at 520nm of fluorescein labeled scCroPFPS-AWSG with excitation at 490nm was
plotted as a function of OR3-R concentration. The concentration of scCroPFPS-AWSG was fixed at
1nM and the concentration of OR3-R was varied from 0nM to 30nM. The solid line is the fit of
data to equation (2-7) and Kd = 0.84nM was obtained. The value is the average of the results of 3
experiments.
Inset Spectra shows the decrease of scCroPFPS-AWSG fluorescence as a function of OR3-R
concentration.

67

3.6

x 10

5

3.4

Fluorescence (cps)

3.2
3
2.8
2.6
2.4
2.2
2
1.8

0

0.5

1

1.5

2

[DNA(Ot)] (M)

68

2.5

3

3.5
x 10

-8

Figure 3.6 Equilibrium dissociation constant (Kd) of scCroPFP-AWG binding operator
DNA (OR3) by competition experiment
Figure shows the fit of Kd from a typical experiment
The mixture of 1nM scCro-IAF and 1nM OR3-R was titrated by 0nM to 300nM scCroPFPS-AWSG.
The solid line is the fitting of the fluorescence as a function of scCroPFPS-AWSG concentration to
equation (2-14). Kd = 1.24nM was obtained. The value is the average of the results of 3
experiments.
(inset) Spectra shows the increase of scCro-IAF fluorescence as a function of scCroPFPS-AWSG
concentration.
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3.4 DISCUSSION
3.4.1 Labeling 5-IAF at the single cysteine has barely effect on DNA binding affinity
Using fluorescence energy transfer, the parameters of scCro variants operator DNA
interactions have been measured under native conditions. scCro variants operator DNA
interactions were monitored by the change of donor fluorescence since almost all the
fluorescence is from the 5-IAF at 520nm when it is excited at 490nm. The FRET method
requires the reactants to be labeled with fluorescent probes (donor and acceptor pair). Several
cysteine variants were constructed and used to study the folding and dimerization processes.
Single cysteine variants of Cro were constructed by Jia et al., 2005 to identify surface exposed
positions in the protein where fluorophores could be conjugated with minimal effects on protein
structure, stability dimer assembly or DNA binding. Among the cysteine variants that best met
those criteria is N-terminally extended protein that adds a His-6 purification tag and a unique
cysteine residue to the unstructured N-terminus of Cro. Nhis-C3-scCroPFPS-AWSG was constructed
by adding a single cysteine in a Histidine Tag (N-C3-(H)6): MGCS(H)6SSGL) at the unstructured
N terminus of scCroPFPS-AWSG. This construction allows us to label the proteins with fluorescent
probes (5-IAF) and employ the fluorescence resonance energy transfer (FRET) technique to
characterize kinetic rates and equilibrium extent.
The equilibrium of scCro variant binding to operator DNA was investigated by two
methods: direct titration experiments and competition experiments. Direct titration experiments
were carried out by titrating 1nM 5-IAF labeled scCroPFPS-AWSG with rhodamine labeled operator
DNA with the range of 0-30nM. Competition experiment was performed by addition of
unlabeled scCroPFPS-AWSG to the 5-IAF labeled scCro and rhodamine labeled operator DNA
71

complex. Although it is predicted that scCroPFPS-AWSG binds to operator DNA weaker than scCr,
the presence of a large excess of unlabeled scCroPFPS-AWSG will replace almost all the scCro from
the scCro-operator DNA complex and the process changed to the reaction between unlabeled
scCroPFPS-AWSG with operator DNA. A Kd of 1.2nM was obtained by titration experiments and
0.8nM from competition experiment. Agreement of the competition experiments and the direct
titration experiments show that the label at the single cysteine has small if any effect on binding
affinity.

3.4.2 Proline residues replacement of scCro significantly accelerates the kinetics of the
binding of wild type Cro for operator DNA
At nanomolar concentrations that are typical for DNA binding most free wild type Cro
subunits exist as isolated monomers. Cro monomer has to assemble first before binding to DNA.
The slow assembly process takes hundreds of seconds which result in the slow association with
operator DNA (ka ≈ 2 x 105 M-2s-1). Proline isomerases can certainly accelerate Cro dimer
assembly from the unfolded state in vitro (Satumba and Mossing 2002). Fluorescence and CD
experiments have shown that Cro refolding from denatured states is limited by the slow trans 
cis isomerization at Pro 59 (Satumba and Mossing 2002; Al-Duraibi 2006). All Cro variants and
conjugates have a similar slow folding rate of 0.006 s-1, a typical rate of proline isomerization
(Reimer, Scherer et al,. 1981). All the peptide bonds in the Cro subunits are in the trans
configuration except F58-P59. Slow phase is owing to the cis/trans isomerization of a prolyl
bond to its native conformational state, a well-known phenomenon in the slow kinetic phases in
the refolding of proteins (Brandta, Halvorson et al,. 1975; Ficher, Tradler et al,. 1998).
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Single-chain Cro variants, constructed by connecting C-terminal of one subunit and Nterminal of the next one with a short polypeptide linker (AGTGGSGG) (Jana, R; 1998), contain
2 DNA-binding domains within a single polypeptide. Single-chain Cro enhances the stability and
DNA binding affinity (Jana, R; 1998). ScCro variants eliminate the slow dimer assembly process
and show hundreds of times faster association (ka = (2.12 0.93) x 108 M-1s-1 for scCro and
(7.8 0.9) x 108 M-1s-1 for scCroPFPS-AWSG as showed in Figure 3.3 with operator DNA (OR3)
than wild type Cro. It takes about 103 seconds for wild type Cro to associate with OR3 but less
than 10 seconds for scCro dimers. Refolding of scCro however is slow with a rate similar to the
proline isomerization limited rates observed in the dimer and engineered monomer. It may worth
to trade off some DNA binding affinity for a faster folding rate in scCro mutant.
Any perturbation of the amino acid sequence of a protein can affect that protein„s
stability. Residues of A52, E54, K56 and F58 close to the C-terminal part of the polypeptide
chain are believed to have a significant role in maintaining the folded conformation of Cro dimer.
Substitutions of two prolines (P57 and P59) of scCro result in the loss of the hydrophobic
interactions between the proline ring and the aromatic residue (F58) in scCro. Kinetics studies
indicate that the association and dissociation rate constants are both accelerated 3 orders of
magnitudes. This result suggests that the distortion induced by the prolines replacement in this
variant not only affects the stability but also the rate of assembly of the scCroPFPS-AWSG-operator
complex. This interesting discovery prompted us to investigate the other physical properties of
scCroPFPS-AWSG, like salt dependence and nonspecific DNA interactions.
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Table 3.2 Kinetics and Equilibrium Constants of Cro Variants-Operator DNA Interactions
in KP200
The average values from 3 – 6 repeats including error estimates are given in the tables shown
below.
ka
kd(s-1)
Kd
wtCro

2.1 ± (0.6)X105(M-2s-1)

1.6 ± (0.46)X10-4

8.2 ± (0.9)X10-10(M2)

scCro

2.12 ± (0.93)X109(M-1s-1)

6.1 ± (0.62)X10-4

1.42 ± (0.57)X10-11(M)

7.8 ± (0.9)X108(M-1s-1)

1.06 ± (0.11)

1.2 ± (0.7)X10-9(M)

scCroPFPSAWSG
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3.4.3 Single-chain Cro variant has a close binding affinity to wild type Cro.

The general prediction that prevention of dimer dissociation would enhance DNA
binding affinity has been confirmed by linking two domains of several proteins. Some of these
proteins are unfolded by themselves and bind to DNA only as a folded dimer (as in a designed
single-chain Arc repressor). The linker can keep them as a folded dimer so that it is always
DNA-binding-competent (Zhou, 2001). Single-chain Cro dimers such as scCro8 which the two
subunits were connected by an 8 residue linker reduce the concentration of Cro subunits required
for half saturation of an operator site by approximately 250-fold (Jana, 1998). Therefore the
binding affinity for operator DNA was enhanced hundreds of times. The enhancement of affinity
can be attributed almost entirely to an increased rate of Cro-DNA complex formation as the
dissociation rate for the dimer-DNA complex is very similar to rate of the wild type Cro-DNA
complex.
As the substitution of prolines in scCro dimer leads to the loss of the stability of the
scCro dimer due to the change at the interface of the Cro dimer. It turns out that scCroPFPS-AWSG
accelerates not only the association rate but also the dissociation rate of the dimer-DNA complex.
Therefore the binding affinity of scCroPFPS-AWSG to operator DNA is lower than scCro (Table 3.2)
to the level that close to the affinity of wild type Cro operator DNA binding. Single-chain Cro
variant prevents the dimer dissociation but does not enhance the binding affinity of wild type Cro.
These interesting observations result in our subsequent investigations of the parameters of
scCroPFPS-AWSG DNA interactions under other energetic driving forces to uncover the codes for
efficient gene control.
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CHAPTER IV
COMPETITION FROM SMALL IONS AND NONSPECIFIC DNA
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4.1 SINGLE-CHAIN CRO VARIANTS-NONSPECIFIC DNA INTERACTIONS
4.1.1 INTRODUCTION
Typical physical environment in vitro assay conditions is extremely different from the
physical environment inside a cell. In addition to 6 primary sites for Cro binding in the lambda
genome there are many alternative sites where weaker binding could occur. The total length of
the lambda genome is 48,502 nucleotide pairs [GenBank: J02459.1]. Inside an E. coli cell there
are another 4.6 million base pairs of bacterial genomic DNA which compete with specific
binding sites for the proteins involved in genetic regulation. As a result, although the binding of
these proteins to nonspecific DNA is relatively weak, a large fraction of DNA-binding proteins is
likely to bind to nonspecific sites. The binding specificity of a protein is determined by the
difference in binding affinities of the protein for the specific versus the non-specific sites (Eric
and Bustamante, 1994). Based on simple equilibrium consideration, specificity is defined in
quantitative term as the ratio of the affinity of protein binding to operator sites (KOP) over the
binding affinity of protein for non-specific DNA (KD), expressed as KD/KOP (Lin, s. and Riggs,
A.D. 1975). KD/KOP =108 was proposed for lac repressor on the assumption that E.coli can be
considered as a uniform polymer with identical non-operator sites and every base pair is
potentially the beginning of a binding site and the effective concentration of the “average”
binding sites is just the concentration of base pairs in the DNA (Lin and Riggs. 1972),. Although
the specificity of lac repressor for lac operator is very high, it is limited and it will be seen that
the affinity for non-operator DNA has important consequences for in vivo regulation (Lin, s. and
Riggs, A.D. 1975).
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Calculations based on a thermodynamic analysis of lac repressor-operator interactions in
E. coli indicate that a typical cell contains about nine repressor molecules bound to nonspecific
sites, one repressor bound to the operator site, with much less than one repressor in a free state
(Von Hippel et al., 1974). The ratio of the number of repressor molecules binding to nonspecific
sites to specific sites indicates that non-specific DNA binding is crucial in controlling the
concentration of free regulatory protein inside cell and consequently affects the cellular function.
Here we characterized the binding affinity of wild type Cro and scCro variants for
nonspecific DNA and compared the specificity of these Cro proteins binding to non-specific
DNA over operator DNA. The ratios of numbers of Cro proteins binding to non-specific sites to
the numbers binding to the specific sites (Nns/Ns) were also estimated.
As shown in the last chapter, scCro variants bind hundreds of times faster and more
tightly to operator DNA than wild-type Cro as they eliminate the slow dimerization process. Do
the scCro variants behave the similar way for nonspecific DNA interactions?
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4.1.2 MATERIALS AND METHODS
4.1.2.1

Buffers and Reagents

KPL buffer contains 20 mM potassium phosphate, 2 M lysozyme (Sigma) at pH 7.0;
KP20 buffer contains 20 mM potassium phosphate, 1mM EDTA, and 1.4 mM 2mercaptoethanol (ME) at pH 7.0; KP50, KP100 and KP 200 buffer is KP20 plus 50, 100 and
200 mM potassium chloride respectively. For most experiments using KP20 and KP200 buffers,
100 g/ml of bovine serum albumin (BSA, ordered from Sigma) and 5% (v/v) glycerol were also
added for protein stability and fluorescence signal measurements. All experiments were carried
out at 25 °C unless otherwise indicated. Salmon sperm DNA (purchased from Qbiogene and
prepared in TE buffer, pH 8.0.) was used as nonspecific DNA substrate in competition
experiments.
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4.1.2.2

Non-specific DNA Preparation

122.5 mg dried salmon sperm DNA was weighed and cut with a scissors to small fibers.
In a 50 ml Falcon tube, 20ml sterilized TE buffer was added to dissolve the fibers at 4°C
overnight. The viscous dissolved salmon sperm DNA solution was sonicated at about 30% power
for a minute at a time for about ten cycles until the solution becomes less viscous. Comparing
with 2-log DNA ladder in 0.8% agarose gel, the size range of sonicated salmon sperm DNA was
between 150bp and 2000bp.The concentration was 6.22mM(bp) measured by UV
Spectrophotometry. The DNA solution was diluted to 100μM(bp) and dispensed in 1ml aliquots,
and stored at -20°C for repeated usage.
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4.1.2.3

Competition Experiments to Determine the Equilibrium Constants of
scCro Variants-non-specific DNA Interactions

Equimolar (2nM) pre-equilibrated scCro variants labeled with 5-IAF and operator
DNA (OR3) labeled with rhodamine were mixed and equilibrated for about 15 minutes. A
small amount of high concentration (1mM) of non-specific DNA (salmon sperm DNA,
nsDNA) was added into the mixture solution. The intensity of the fluorescence increased as
the release of scCro variants from operator DNA by the competitive binding of nsDNA. The
titration was continued until no change of the intensity of the fluorescence was detected.
Equilibrium constants of scCro variants-non-specific DNA interactions were estimated
by equation (5-33) (showed in appendix A) when half of scCro variants was replaced in scCro
variants-DNA complex (when θ = 1/2).
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4.1.3 RESULTS
4.1.3.1

Nonspecific DNA Binding Versus Specific DNA Binding

Table 4-1 summarizes the equilibrium constants of scCro variants-DNA interactions
specifically and nonspecifically.
All the experiments were carried out in KP20 buffer containing 200mM KCl at 250C.
Equilibrium dissociation constants were calculated from equation (5-33) when operator DNA
achieved half saturation. The binding affinities to nsDNA for wild type Cro and scCro variants
are relatively weak comparing with operator DNA binding, the nsDNA interactions are over 105
fold weaker than specific DNA binding for all three Cro proteins. The ratios of numbers of Cro
proteins binding to non-specific sites to the numbers binding to the specific sites (Nns/Ns) are also
showed in Table 4-1.
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Table4-1 Equilibrium Dissociation Constants of Cro Variants- operator DNA
and nonspecific DNA interactions in KP200 buffer

Equilibrium
dissociation constant

wtCro

scCro

Kd-s (M)

8.2 ± (0.9) x 10 -10(M2)

1.42 ± (0.57) x 10 -11

1.2 ± (0.7) x 10-9

Kd-ns (M.bp)

1 x 10-4(M2.bp)

2.8 ± (1.1)x 10-6

3.8 ± (1.3) x 10-4

Kd-ns/Kd-s

105

2x105

3x105

Nns/Ns

10

5

3
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scCroPFPS-AWSG

4.1.4 Discussion
The interactions of scCro variants with non-specific DNA (salmon sperm DNA) have
been investigated by competition experiments.
Studies in vitro indicate that wild type Cro and scCro variants will bind nonspecifically to
the E. coli chromosome in vivo. The non-specific DNA binding affinity is 10-4M for wild type
Cro and scCroPFPS-AWSG and 10-6M for scCro. These non-specific DNA interactions with Cro
proteins are significant. Here specificity is defined as Kd-ns/Kd-s. For the three Cro proteins, the
specificities (Kd-ns/Kd-s) are about 105. In E.coli cell there is about a 106 fold excess of nonspecific DNA binding sites over operator DNA binding sites. The ratios of numbers of Cro
proteins binding to non-specific sites to the numbers binding to the specific sites (Nns/Ns) showed
in Table 4-1 indicates that Nns/Ns is 10 for wild type Cro while 5 for scCro and 3 for scCroPFPSAWSG.

These numbers agree with the values estimated by Bakk and Metzler (2004) that 86% of

the total number of CI repressors is nonspecifically bound. Although the specific DNA binding
shows extremely higher affinity than nonspecific DNA binding, the presence of overwhelming
preponderance of nonspecific DNA binding sites trap more protein molecules than operator
binding sites. A large number of low affinity sites will compete just as well as a small number of
high affinity sites (Lin and Riggs, 1975). From Table 4-1 it seems that a slightly bigger
proportion of wild type Cro molecules binding to nonspecific DNA Than scCro variants. This
result may be explained by that the presence of plenty of non-operator DNA results in faster
formation of Cro monomerDNA complex, which is followed by recruitment of the second
monomer to form the final complex (Jia, Satumba et al. 2005).
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Under the assumption that the repressor([RT]) is in large excess over the operator([OT])
and [RT]>> KOP (the affinity of repressor binding to operator sites) and non-operator DNA [DT]>>
KD (binding affinity of repressor for non-specific DNA), the efficiency of repressor binds to the
operator can be determined by the ratios of KD/KOP and the ratio of RT/DT, expressed as
[ ]⁄[

]

[

]⁄

[

] (KOP and KD are dissociation constants of repressor binding to

operator sites and non-operator sites respectively) (Ptashne, 2004). By applying this general
rule, we estimate that about [ ]⁄
Kao-Huang et al. (1977) that [ ]⁄

in vitro which are close to the values estimated by
as KRD(association constant) in vivo are at least

103M-1 and correspondingly in vivo value of KRO(association constant) must at least 1012M-1.
Wild type Cro and scCroPFPS-AWSG bind to nonspecific DNA much weaker
(Kd-ns ≈ 10-4 M) than scCro which can be account for the less stability of wild type Cro
and scCroPFPS-AWSG than scCro. Comparison of the equilibrium dissociation constants of
scCroPFPS-AWSG and wild type Cro for nonspecific DNA shows that scCroPFPS-AWSG has close
binding affinity to wild type Cro not only for specific DNA but also for non-specific DNA.
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4.2 EFFECTS OF KCL ON SINGLE-CHAIN CRO VARIANTS DNA INTERACTIONS
4.2.1 INTRODUCTION
Subsequent investigations have probed the role of other energetic driving forces (salt
concentration, pH, T) in an effort to uncover the codes for efficient gene control (Koblan &
Ackers, 1991, 1992; Senear & Ackers, 1990). Electrostatics plays an important role in the
stability of proteins and protein-DNA interactions because at a thermodynamic level, proteinnucleic acid interactions may be modeled as ion-exchange reactions, in which the neutralization
of polyelectrolyte charge that occurs upon forming the noncovalent complex is accompanied by
the release of large numbers of electrolyte ions to the bulk solution: protein + nucleic acid ↔
complex + n ions, where typically n >> 1 (Record et al., 1976, 1978, 1985). Consequently, the
equilibrium extent of interaction is a sensitive function of the bulk salt concentration. Cro is a
highly positively charged molecule (+6 per subunit at neutral pH) with pI of 9.9. Thus the
electrostatic effects play a significant role in the interactions between Cro repressor and DNA.
The in vitro sensitivity of protein-DNA interactions to the nature and the concentration
electrolyte ions (effects which are species-specific and not ionic strength effects) suggests that
protein-DNA interactions should be affected by the same variables in vivo. Given the sensitivity
of protein-DNA interactions to electrolyte activity observed in vitro and the variability of the
intracellular ionic environment, it is important to quantify the changes that occur in the activities
of intracellular electrolyte ions and the possible effects of these variations on protein-DNA
interactions in vivo. In vitro studies of specific and nonspecific protein-DNA interactions
invariably show that both the equilibrium stability of the complex and the kinetics of its
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formation and dissociation are strongly dependent on the activities and types of the
accompanying electrolyte ions.
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4.2.2 MATERIALS AND METHODS
Salt dependence experiments were performed in an Mg2+ free buffer containing 0.02 M
potassium phosphate (pH adjusted to 7 at 25 0C with HCl), 0.05-0.20 M KCl, 100 mg/ml of BSA
and 5% (v/v) glycerol.
In the kinetics studies, association kinetic experiments were performed by mixing same
amount of fluorescein-labeled Cro variants with rhodamine labeled OR3 in the KP20 buffer
containing different concentrations of KCl. Cro variants-DNA complexes were detected via
energy transfer from fluorescein to rhodamine. The decrease in donor fluorescence was
monitored after stopped-flow mixing and the association rate constant was obtained by fitting the
curve to a single exponential function. For the dissociation rate constants salt dependence
experiments, after same amount of fluorescein-labeled Cro variants and rhodamine-labeled OR3
were mixed and equilibrated for 15 minutes, 100 fold excess of unlabeled OR3HP was added to
the mixture to trap free repressor molecules. The kinetics of the irreversible dissociation process
was monitored immediately. The increase of fluorescence observed with 490 nm excitation and
520 nm emissions was monitored by fluorometer or stopped-flow and the data was fit to a single
exponential function to obtain the rate constant. The average of rate constants from 6 repeats
including error estimates are given either in the text or in the tables as shown later.
In the equilibrium studies, the equilibrium dissociation constants can be obtained by
calculations of the ratio of dissociation rate constant to association rate constants in different salt
concentration buffers or by direct titration and competition experiments.
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4.2.3 RESULTS
4.2.3.1

[K+] effects on scCro-DNA Interactions

4.2.3.1.1 Kinetics of scCro-DNA Interactions on [K+]
Table 4-2, Figure 4.5 and 4.6 summarize the [K+] effects on the kinetics of scCro-DNA
interaction. The association of scCro dimer with operator DNA shows no dependence on salt
concentration in the range (0.05-0.2M KCl) investigated. The dissociation of scCro dimer with
operator DNA shows moderate dependence on salt concentration in the range (0.05-0.2M KCl)
investigated. Dissociation rate constant increases by 2 orders of magnitude over this range.
Figure4.5 and 4.6 show the plots of logarithm of ka and kd of scCro-operator DNA as a function
of the logarithm of the [K+]. The slope of the log-log plot of kdsc vs. [K+] is 3.2, indicating that
the net uptake of the thermodynamic equivalent of approximately 3 ions occurs prior to or as part
of the rate-limiting step of the dissociation reaction (Roe et al., 1984; Lohman et al., 1978).
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Table 4-2 [K+] effects on the kinetics of scCro-operator DNA interactions
[K+] (M)

ka-sc (M-1s-1)

kd-sc (s-1)

0.05

1.15 ± (0.53) x 109

7.32 ± (0.53) x 10-5

0.1

1.25 ± (0.35) x 109

9.4 ± (0.5) x 10-4

0.2

2.12 ± (0.93) x 109

6.1 ± (0.62) x 10-3
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4.2.3.1.2 Equilibrium constant (Kd) of scCro-DNA interactions on [K+]
Table 4-3 and Figure 4.1 show the [K+] effects on the equilibrium constant of scCro-DNA
interaction. We observed a moderate effect of [K+] on the equilibrium constant of scCro-operator
DNA interaction. Kd increases by 2 orders of magnitude over the salt range investigated. The
log-log plot of Kd versus [K+] in Figure 4.2 gives a slope of 4 which indicates that the ionexchange stoichiometry for the overall binding process in KCl is approximately 4:
scCro + operator DNA (OR3) ↔ complex + 4 monovalent ions
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Table 4-3. [K+] effects on the equilibrium constant of scCro-operator DNA
interactions
[K+] (M)

Kd-sc (M)

0.05

6.35 ± (1.1) x 10-14

0.1

8.70 ± (0.90) x 10-13

0.2

1.42 ± (0.57) x 10-11
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Figure 4.1 Dependence of equilibrium constants of scCro-operator DNA on [K+]
The solid line is the linear fit to the data:
(

)⁄ (

[

])

Log

[K+]

-10
-10.5

Log (Kd)

-11
-11.5
-12
-12.5
-13
-13.5
-14
-1.5

-1

-0.5
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4.2.3.2

Effects of [K+] on scCroPFPS-AWSG -DNA interaction

4.2.3.2.1 Kinetics of scCroPFPS-AWSG-DNA interactions on [K+]
Table 4-4 and Figure 4.5 and 4.6 summarize the [K+] effects on the kinetics of scCroPFPS-AWSG
specific DNA interaction. The association of scCroPFPS-AWSG with operator DNA shows no
evident dependence on salt concentration in the range (0.05-0.2M KCl) investigated. The
dissociation of scCroPFPS-AWSG with operator DNA shows moderate dependence on salt
concentration in the range (0.05-0.2M KCl) investigated. kd increases by 3 orders of magnitude
over this range. Figure4.5 and 4.6 show the plots of logarithm of ka and kd of scCroPFPS-AWSG operator DNA as a function of the logarithm of the [K+]. The slope of the log-log plot of
kd(scCroPFPS-AWSG) vs. [K+] is 4.8, indicating that the net uptake of the thermodynamic equivalent
of approximately 5 ions occurs prior to or as part of the rate-limiting step of the dissociation
reaction.
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Figure 4.2 [K+] effect on observed dissociation of scCroPFPS-AWSG-operator
complex
The increase in fluorescence observed with 490 nm excitation and 520 nm emissions due to
energy transfer is plotted vs. time for equimolar mixtures of fluorescein labeled scCroPFPS-AWSG
and rhodamine labeled operator DNA.
As the salt concentration increased from 50mM KCl to 100mM KCl and finally 200mM KCl, the
scCroPFPS-AWSG -operator DNA complex dissociation half-life decreased from 3000seconds to
10seconds and the extent of binding decreased as well.

Relative Fluorescence

(inset) Shows the amplification of the bigger graph from 0 to 60seconds.

95

Table 4-4: Effect of [K+] on the kinetics of scCroPFPS-AWSG specific DNA binding

[K+] (M)

ka(scCroPFPS-AWSG) (M-1s-1)

kd(scCroPFPS-AWSG) (s-1)

0.05

2.43 ± (1.0) x 108

1.38 ± (0.23) x 10-3

0.1

3.02 ± (0.93) x 108

3.02 ± (0.28) x 10-2

0.2

7.8 ± (0.9) x 108

1.06 ± 0.11
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4.2.3.2.2 Equilibrium constant (Kd) of scCroPFP-AWG specific DNA interaction
on [K+]
Table 4-5 and figure 4.3 show the [K+] effects on the equilibrium constant of scCroPFPS-AWSG
specific DNA interaction. We observed a moderate effect of [K+] on the equilibrium constant of
scCroPFPS-AWSG-operator DNA interaction. Kd increases by 3 orders of magnitude over the salt
range investigated. The log-log plot of Kd versus [K+] in figure 4.4 gives a slope of 3.8 which
indicates that the ion-exchange stoichiometry for the overall binding process in KCl is
approximately 4:
scCroPFPS-AWSG + operator DNA (OR3) ↔ complex + 4 monovalent ions
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Table 4-5. [K+] effects on the equilibrium constant of scCroPFPS-AWSG-operator DNA
interactions

[K+] (M)

Kd-scCroPFPS-AWSG (M)

0.05

6.30 ± (1.3) x 10-12

0.1

8.50 ± (1.6) x 10-11

0.2

1.2 ± (0.70) x 10-9
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Figure 4.3 Dependence of equilibrium constant of scCroPFPS-AWSG -operator DNA
on [K+]
)⁄ (

The solid line is the linear fit to the data: (
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])
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4.2.3.3

ScCro variants –nonspecific DNA binding on [K+]

Table 4.6 and Figure 4.4 show the equilibrium constants of scCro variants-nonspecific
DNA interaction on [K+]. The values are the average of 3 repeats including error estimates.
The interaction of scCro with nonspecific DNA is slightly dependent on [K+]. Kd
decreases by 2 orders of magnitude from 0.05 M KCl to 0.2 M KCl. From a plot of log Kd vs. log
[K+] in Figure 4.4, it is apparent that the ion-exchange stoichiometry for the overall process of
open complex formation at scCro in KCl is approximately 3.
The interaction of scCroPFPS-AWSG with nonspecific DNA has a stronger dependence on
[K+]. Kd decreases by 5 orders of magnitude from 0.05 M KCl to 0.2 M KCl. The log-log plot of
Kd vs. [K+] in Figure 4.4 gives a slope of 8.8 which indicates that the ion-exchange
stoichiometry for the overall process of open complex in KCl is approximately 9. scCroPFPS-AWSG
+ nonspecific DNA ↔ scCroPFPS-AWSG -nsDNA + 9 ions
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Table 4-6 Equilibrium dissociation constants of sc Cro variants non-specific DNA binding
on [K+]

[K+]

0.05M

0.1M

0.2M

Ksc-ns (M.bp)

3.2 ± (1.8) x 10-8 5.8 ± (1.4) x 10-7

2.8 ± (1.1) x 10-6

KscCro PFPS-AWSG-ns (M.bp)

1.9 ± (1.6) x 10-8 2.1 ± (1.7) x 10-6

3.75 ± (1.3) x 10-4
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Figure 4.4 Effect of [K+] on equilibrium dissociation constant of scCro variants
non-specific DNA binding
The solid lines are the linear fits to the data:
)⁄ (
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4.2.4 DISCUSSION
4.2.4.1

Similar Salt Dependence on scCro Varants Specific DNA binding

Numerous physical and chemical variables act to affect the physiological behaviors of the
biological circuits. In particular, noncovalent interactions are responsible for both the stability
and the specificity of assembly of the protein-DNA complexex involved in gene expresson and
its controling (Record, ). The dominant noncovalent forces for macromolecular interactions
hydrophobic effect, polyelectrolyte effect. In addition to the main function of hydrogen bond
and hydrophobic interactions in assembly of Cro protein–operator DNA complex, the ion
exchange also play an important role. The large effects of ion concentrations have been observe
on the rate of open complex formation between RNA polymerase and the XPR promoter and are
a dominant characteristic of the kinetics and equilibria of protein-nucleic acid interactions and
nucleic acid conformational equilibria (Roe and Record, 1985).
Determination of the behavior of equilibrium dissociation constant as a function of
solution variables, like salt concentration, is necessary in order to understand the contributions of
ionic and other noncovalent interactions to the overall binding free energy under specified
conditions. Here we studied the effect of small cation (K+) on the kinetics and equilibrium
constant of Cro variants DNA binding specifically and nonspecifically. The assembly of scCro
variants with operator DNA did not show significant dependence on salt concentration in the
range investigated. The dissociation process of scCro variants operator DNA complex becomes
faster from hour orders to a few seconds as the salt concentration increases. Figure 3.5 shows the
increase of relative fluorescence, as dissociation of scCroPFPS-AWSG -operator DNA occurs, versus
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time under different [K+]. This result suggests that the stability of the complex decrease with the
[K+] increase from 0.05M to 0.2M.
Lambda regulatory protein Cro variants carry 6 net positive charge per unit around their
binding

site.

DNA

is

a

polyelectrolyte.

The

high

charge

density

of

the

phosphodiester backbone results in condensation of counterions to neutralize the bulk of the
charge on the phosphates. The polyelectrolyte effect in the reaction of Cro vriants and DNA
arises from tighly bound counterions that are displaced during the formation of complexes. The
formation of the Cro variants-DNA is accompanied the release of cations into the solution. The
salt effect on the equilibrium dissociation constant indicates that every molecule of scCro
variant-operator DNA assembly will release about 4 ions into solution. The specific DNA
binding by scCro repressor involves about 4 charge-charge interactions.
The kinetics of scCro variants-operator DNA interactions on [K+] indicates that the
dependence of the equilibrium constant on the 4th power of the salt concentration is almost
entirely contributed by dissociation rate constant. Contrast the effect of [K+] on the equilibrium
dissociation constant (Kd) of scCro variants operator DNA interactions to wild type (Q3C) Cro–
operator DNA binding showed in Table 4-7 and Figure 4.6, similar salt dependence observed.
For a typical reaction of scCro variants DNA interactions the rate of association is propotial to
the concentration of the free scCro molecules and free DNA molecules while rate of dissociation
is related to the concentration of scCro-DNA complex and 4 power of cation concentration. As
an reactant in the dissociation process of the complex, cation affect the interaction of scCro
variant and DNA mainly on the disassembly of the complex.

104

Figure 4.5 Dependence of Association Kinetics of scCro Variants-OR3 on [K+]
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The solid lines are linear fits to the data: (
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Figure 4.6 Dependence of Dissociation Kinetics of scCro Variants - OR3 on [K+]
The solid lines are linear fits to the data:
)⁄ (

[

])

;

)⁄ (

(

[

.

])

1
kdsc
0

Log (kd)

(

kdsc(PFP-AWG)

-1
-2
-3
-4
-5
-1.5

-1.3

-1.1

-0.9

Log [K+]

106

-0.7

-0.5

Table 4-7. Dependence of

Equilibrium Constants of Cro Variants-

operator DNA interactions on [K+]

[K+] (M)

Kd-Q3C

Kd-scPFPS-AWSG (M)

Kd-sc (M)

0.05

2.96 ± (1.4) x 10-12(M2)

6.30 ± (1.3) x 10-12

6.35 ± (1.1) x 10-14

0.1

4.06 ± (1.1) x 10-11(M2)

8.50 ± (1.6) x 10-11

8.70 ± (0.90) x 10-13

0.2

8.2 ± (0.9) x 10 -10(M2)

1.2 ± (0.70) x 10-9

1.42 ± (0.57) x 10-11
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4.2.4.2

Different salt sensitivity of scCro variants nonspecific binding

A variety of physiological and genetic conditions should be taken into account in the vitro
experiments in order to apply the physical parameters obtained in vitro experiments on predicting
the outcome of the vivo investigations. Small ions are one of the most important components
affecting the regulatory protein-DNA interactions which control gene expression.
Non-specific DNA bind of lac repressor is thought to involve primarily interactions of
DNA phosphate groups with cationic groups on lac repressor, accompanied by displacement of a
large number of cations from the DNA (Ha et al, 1992). Record and his coworkers also showed
that nonspecific binding of proteins to DNA is purely electrostatic and can be quantitatively
explained in terms of competitive condensed counterion displacement from the DNA by
polycationic proteins.
Here we studied [K+] effects on scCro nonspecific binding by competition experiments.
Our calculations by fitting data to equation (4-10), based on simple equilibrium considerations,
imply that salt dependencies of specific and nonspecific binding are nearly identical for scCro
(log-log plots of Kdsc and Kdsc-ns vs [K+] give a slope of 4) but drastically different for scCroPFPSAWSG

where the log-log plots of Kdsc- PFPS-AWSG and Kdsc-PFPS-AWSG-ns vs [K+] give slopes of 4 and 9

respectively. Approximately nine charge-charge interactions occurred in the formation of
scCroPFPS-AWSG repressor-non-specific DNA complex. The difference of salt sensitivities between
non-specifically binding of scCro and scCroPFPS-AWSG probably due to the less stable structure of
scCroPFPS-AWSG compared to scCro. scCro was shown to enhance thermal stability of wild type
Cro. The more stable scCro binds to operator DNA and non-operator DNA with similar interface.
Similar amount of cations were replaced by the polycationic protein. scCroPFPS-AWSG has a more
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loose structure than scCro. A larger binding interface between non-specific DNA and scCroPFPSAWSG

may be formed when they assemble. Therefore more surface of the non-specific DNA was

involved in the reaction and more cations were thus released to the solution. Comparison of the
KCl effects on binding to the operator sites of OR3 and to non-specific DNA shows apparent
differences in the slopes of log-log plots (Figures 4.3 and 4.4). These slopes reflect about 9
counterions removal from the DNA upon scCroPFPS-AWSG binding. The result is supported by
Takeda et al. that showed the analysis of the ionic-strength dependence of nonspecific Cro-DNA
association by an electrostatic model (Manning et al. 1978, Record et al. 1978) suggested the
release of about nine univalent cations. This result suggests that scCroPFPS-AWSG-nonspecific DNA
interaction is predominantly electrostatic. Given the magnitude of these ion effects and the
variability of the intracellular ionic environment, it is clear that these changes in vivo ion
concentrations must play a global regulatory role in the initiation of transcription and on
numerous other steps in gene expression.
On and off of genes is controlled by the binding of regulatory proteins for specific DNA.
The phage lambda can switch from one state (lysogeny) to another (lytic growth) in response to
an external signal (Johnson et al. 1981). To understand the physical principles that govern the
ways in which the protein-DNA and protein-protein interactions operate in concert to produce
the known physiological behavior many models of dimers assembly and repressor DNA
complexes were proposed out. Model based on statistical thermodynamic assumptions is thought
sufficient to account for some of the known physiological properties of the repressor-operator
regulatory system (Ackers et al. 1981). According to the principles of the statistical
thermodynamic model that the physiological behavior of genetic system is governed by
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thermodynamic energies which are related to binding affinities, we can imagine that same
concentration proteins with the same binding affinities for DNA will function similar in the
model. We think the kinetics mechanism is also important in controlling the physiological
behavior of the genetic switch.
Our goal going to this dissertation is the construction of a protein which can separate the
kinetics from thermodynamics by eliminating the slow assembly process. Kinetic and
equilibrium extent studies in this dissertation showed that the engineered scCro has a similar
binding profile to wild type Cro except that hundreds of times faster kinetics. Under the premise
of the statistic thermodynamic models if we replace wild type Cro with scCroPFPS-AWSG it will not
affect the physiological behavior of the switch since they have a similar binding affinity. The
selection of lytic or lysogenic life cycles by the lambda genetic switch lies on the winner of the
competition between the two regulatory repressor: CI and Cro. The relative slow folding and
association of Cro subunits puts Cro at a disadvantage. Single-chian Cro variant eliminates the
slow dimerization process and may consequently change the outcome of the switch. The
predicted properties in vitro will be compared with those observed in vivo and the assumption
will be evaluated in vivo.
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5.1.1 Direct Titration Experiments of scCroPFP-AWG variant-DNA binding
From the spectra of labeled protein and labeled OR3 (Figure2.1) we can see that rhodamine has a
very small contribution to the fluorescence at 520nm after excitation at 490nm. The fluorescence
arose almost completely from fluorescein labeled proteins.
Let M = scCroPFP-AWG and O = operator DNA, there is
Ft(520nm) = FM(520nm) [M] + FMO(520nm) [MO]

(5-1)

Where Ft(520nm) is the total fluorescence
FM(520nm) is the contribution of fluorescence from donor [M]
FMO(520nm) is the contribution of fluorescence from complex [MO]
[M] is the concentration of protein labeled with donor dye
[MO] is the concentration of protein-DNA complex
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Substituting [M] and [MO] in equation (5-1) with equation (5-3) and equation (5-4) gives
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Direct titration experiments to get the equilibrium dissociation constant were carried out by
titrating a small amount of protein ([M]) with excess of DNA ([O]) (from 0nM to 30nM). Before
titration, FD(520nm) = Fmax / [Mt]. At the end of titration, almost all the protein binds to DNA ([M]
<< [MO]) and FMO(520nm) = Fmin / [Mt].
Equation (5-5) can be written as below:
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Rearranging equation (6) gives
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5.1.2 Competition experiment to obtain Kd of scCroPFPS-AWSG binding to OR3
In the competition experiments, there are two binding reactions proceed.
(Given C = scCro, M = scCroPFPS-AWSG, O = operator DNA)
C + O ↔ CO
M + O↔ MO
The mass-action equations describing these reactions are (Kc, dissociation equilibrium
constant of scCro-OR3 interactions; Km, dissociation equilibrium constant of scCroPFP-AWG OR3 interactions):
([ ]
([

[
]

])([ ] [
[ ]
[

])([
[

]

]
[

[
]

])
[

])

]

(

)

(

)

Combining equation (5-8) and equation (5-9) gives
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In the competition experiments, M>>MO, so we assume that Mt – MO ≈ Mt.
Rearranging equation (5-10) and Ө = [CO] /[Ct] gives
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Solving the quadratic equation (5-11) gives
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The contributions of the fluorescence signal are from free scCro and scCro-DNA complex.
Ft(520nm) = Fsc(520nm) [C] + Fsc-DNA(520nm) [CO]
Ft(520nm) = Fsc(520nm) ([Ct] – [CO]) + Fsc-DNA(520nm) [CO]

(5-13)

Substitute CO with Ө = [CO]/[Ct] and rearranging equation (2-6) gives
Ft(520nm) = Fsc(520nm) [Ct] – (Fsc(520nm) - Fsc-DNA(520nm) ) [Ct] Ө
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(5-14)

5.1.3 Competition experiment to obtain Kd of wtCro binding to OR3
The competition experiment for wild type Cro replacing scCro in scCro-operator DNA
complex is similar to the competition experiments for scCroPFPS-AWSG except that there are
three reactions in the solution.
(Given C = scCro; M = wtCro; O = operator DNA; K1, K2, K3 are equilibrium dissociation
constants for wild type Cro dimerization, wild type Cro dimer-operator DNA interaction and
scCro-operator DNA binding )
M + M ↔ M2
M2 + O ↔ M 2 O
C + O ↔ CO
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The distributions and relationship of three reactants in the solution are:
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As Ө = [CO] / [Ct], [CO] = [Ct] Ө and [C ]= [Ct] (1- Ө).

Substituting [C] and [CO] in equation (5-15) for K3 with equation (5-19) gives
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Replacing [O], [CO] in equation (5-17) gets
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Combining K1 in equation (5-15), equation (5-20) and equation (5-21) gives
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The assumption of this experiment is that [Ot] = [Ct].
When [C] achieves half saturation, Ө = ½, [O] = K3, B = [Mt] – [Ct].
[ ]
([ ]

)

For the overall reaction of wild type Cro operator DNA binding, there is
↔

Kwt-obs is the apparent equilibrium dissociation constant.
[ ] [ ]
[
]

Combining K1, K2 in equation (5-15) and K wt-obs gives K wt-obs = K1 K2.
Given K1 obtained from previous studies in our lab and K2 calculated from equation (5-23), the
equilibrium dissociation constant of wild type Cro-operator DNA interaction can be estimated by
the equation K wt-obs = K1 K2.
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5.1.4 Competition Experiments to Determine the Equilibrium Constants of scCro
Variants-Non-specific DNA Interactions
In these competition experiments, there are two binding reactions proceed.
(Given C = scCro variant; N = non-specific DNA (ns DNA); O = operator DNA(OR3))
C + O ↔ CO
C + N ↔ CN
The mass-action equations describing these reactions are (K, dissociation equilibrium constant
of scCro-OR3 interactions; Kn, dissociation equilibrium constant of scCro-nsDNA
interactions):
[ ][ ]
[ ]
[ ][ ]
[ ]

(

)

(

)

The distribution of the species in the solution can be expressed as:
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[ ]
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Ɵ represents the fraction of specific DNA binding.
[
[ ]

]
[ ]

Rearranging equation (5-29) and combining equation (5-28) gives
[

]

[

]

[ ]

[

](

)
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Substituting [CO] and [O] in equation (5-24) gives
[ ]

(

)

Replacing [C] and [CO] in equation (5-26) with Equation (5-30) and Equation (5-31) gives
[

]

[

](

)

[ ]

[

]

(

)

Replacing [CN] in equation (5-28) by Equation (5-32) gives
[ ]

[

]

[

](

)

Substituting [N], [C] and [CN] in equation (5-25) gets
{[
[

]

[

](

](

)

}

(

)

)

Kn can be estimated from equation (5-33) and the midpoint of scCro variants specific DNA
interactions titration.
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APPENDIX: B
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This appendix contains several programs used in this dissertation to fit the experiment
data or simulate some models. The scripts of fitwl.m, seconddecrease.m and second.m are used
to determine the association rate constant of single-chain Cro variants perator DNA interactions
from fluorescence data by nonlinear least squares (Figure 3.3). This set of scripts of fitu.m,
increase.m and singleex.m are to fit the dissociation rate constant of single-chain Cro variant
operator DNA interactions (Figure 3.4).
The dissociation equilibrium measurements were carried out by direct titration and
competition methods. The scripts of FF.m and CroDNAkdfit.m were used to fit the data in
direct titration measurements (Figure 3.5). smkdfit.m and Ff.m are scripts to fit the competition
data (Figure 3.6).
All scripts were written in MATLAB.

5.1.5 fitwl.m, seconddecrease.m and second.m to obtain association rate
constant
fitwl.m
function [x, resnorm] = fitwl(data)
xdata = data(:,1);
ydata = data(:,2);
Fp = max(ydata)

%Fp; protein (donor)fluoroscence

x(1) = 1e8 %Initial value of association rate constant
x(2) = 3e5 % Initial value of fluorescence from complex
LB=[];UB=[];
Options=optimset();
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[x, resnorm] = lsqcurvefit('second', x,xdata,ydata,LB,UB,Options,Fp);
%Solve nonlinear curve-fitting (data-fitting) problems in least-squares sense

second.m
function F
A0 = 1e-8
K = x(1)
Fc = x(2)

= second(x, xdata, Fp)
%initial donor concentration (protein concentration)
%association rate constant
%fluorescence from complex(obtained by adding access of DNA
%and assume that almost all the protein bound to DNA)

A = A0./ (2* K * A0 .* xdata + 1) %free donor (free protein)
F = (Fp/A0) .* A + (Fc/A0) .* (A0-A)% total fluorescence
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seconddecrease.m
%script to obtain association rate constant with calling second.m and fitwl.m
file = '4.PRN';
% reads file
data = dlmread(file, '\t', [0 0 100 1]);
% reads data from the first upper left corner to the 100 lower right corner.
[x, resnorm] = fitwl(data);
Fp = max(data(:,2));
%free total donor fluorescence
F = second(x, data(:,1), Fp);
%call fuction second.m
S1 = num2str(x(1), 3);
S2 = num2str(x(2), 3);
subplot(2,1,1), plot(data(:,1), data(:,2),'o', data(:,1), F,'r','linewidth',3)
xlabel('Time (s)','FontSize',18); ylabel('Fluorescence(cps)', 'FontSize',18);
maxt = max(data(:,1))
%max time
maxf = max(data(:,2))
%max F
minf = min(data(:,2))
%min F
text((0.7*maxt), (minf + 0.95*(maxf-minf)), date)
text((0.7*maxt), (minf + 0.7*(maxf-minf)), file)
text((0.7*maxt), (minf + 0.8*(maxf-minf)), 'k =','FontSize',18)
text((0.75*maxt), (minf + 0.8*(maxf-minf)), S1,'FontSize',18)
text((0.7*maxt), (minf + 0.3*(maxf-minf)), 'Fc =')
text((0.75*maxt),(minf + 0.3*(maxf-minf)), S2)
text((0.7*maxt), (minf + 0.1*(maxf-minf)), 'Fi =')
text((0.75*maxt), (minf + 0.1*(maxf-minf)), S3)
resid= data(:,2)- F;
subplot(2,1,2), plot(data(:,1), resid,'.')
hline = refline([0 0]);
set(hline,'color','r','linewidth',3)
title ('residuals','FontSize',18)
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5.1.6 fitu.m, increase.m and singleex.m to obtain dissociation rate constant
fitu.m
function [x, resnorm] = fitu(data)
% x0 = [8e5 .001 1.2e6]; Amplitude, rate constant, F infinity
xdata = data(:,1);
ydata = data(:,2);
x0(3) = max (ydata);
x0(1) = min(ydata)-x0(3);
x0(2) = 0.001 ;%change this manually to best guess for k
[x, resnorm] = lsqcurvefit('singleex', x0, xdata, ydata);
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increase.m
% tells matlab to look in this directory for functions and data
%%increase.m
%script to initialize data
file = '3.prn'
data = dlmread(file, '\t',[0 0 60 1]);
%string is filename
% reads data from the file FILENAME from the first value in the file.
[x, resnorm] = fitu(data);
F = singleex(x, data(:,1));
S1 = num2str(x(1), 3);
S2 = num2str(x(2), 3);
S3 = num2str(x(3), 3);
S4 = num2str (resnorm, 3);
subplot(2,1,1), plot(data(:,1), data(:,2),'O', data(:,1), F,'r','linewidth',2)
xlabel('Time (s)','FontSize',16); ylabel('Fluorescence(cps)', 'FontSize',16);
maxt = max(data(:,1))
%max time
maxf = max(data(:,2))
%max F
minf = min(data(:,2))
text((0.7*maxt), (minf + 1*(maxf-minf)), date)
text((0.7*maxt), (minf + 0.7*(maxf-minf)), file)
text((0.7*maxt), (minf + 0.5*(maxf-minf)), 'k =','FontSize',16)
text((0.74*maxt), (minf + 0.5*(maxf-minf)), S2,'FontSize',16)
%%text((0.7*maxt), (minf + 0.3*(maxf-minf)), 'A =')
%%text((0.75*maxt),(minf + 0.3*(maxf-minf)), S1)
%%text((0.7*maxt), (minf + 0.1*(maxf-minf)), 'Fi =')
%%text((0.75*maxt), (minf + 0.1*(maxf-minf)), S3)
%%text((0.4*maxt), minf , S4)
%legend('smCro', 'Fit of smCro',4)
xlabel('Time (s)','Fontsize',16);ylabel('Fluorescence (cps)','Fontsize',16);
resid= data(:,2)- F;
subplot(2,1,2), plot(data(:,1), resid,'.')
hline = refline([0 0]);
set(hline,'color','r','linewidth',2)
title ('residuals','FontSize',16)
%print –dps
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Singleex.m
function F = singleex(x, xdata)
F = x(1) * exp(-x(2) * xdata) + x(3);
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5.1.7 FF.m, CroDNAkdfit.m and mci.m to fit the data in direct titration
measurements
Crodnakdfit.m
% x(1) =1.0e-11;
x(1) =0.8e-9;
Dt = 1e-9; % Dt = Donor concentrations
xdata = [0
0.1
0.2
0.4
0.8
1
1.4
1.8
2.2
2.6
3
3.6
4.8
7.2
10.8
14.4
18.6
30] * 1e-9;
ydata = [357552
357440
346166
329223
307786
300389
277581
259633
253491
246224
234393
224434
210064
202081
192180
189857
185013
180121];

x(2) = max(ydata);
x(3) = min(ydata);
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LB=[];UB=[]
Options= optimset;%('Tolx',1e12,'MaxFunEvals',1e8,'MaxIter',1e8);
[X,RESNORM,RESIDUAL,EXITFLAG,OUTPUT,LAMBDA,JACOBIAN] =
lsqcurvefit('FF',x,xdata,ydata,LB,UB,Options)
xdata1 = 0:5e-10:3e-8;
B = X(1) + Dt + xdata1;
Y1 = X(2) - ((X(2) - X(3))./Dt*(B - sqrt(B.^2 - 4.*xdata1.*Dt))./2);
plot(xdata,ydata,'o',xdata1,Y1,'linewidth',3);
set(gca,'FontSize',16);
CI = mci(X, RESNORM, JACOBIAN, 0.95);
title('Nhis-c3-SM-Cro DNA Binding');
xlabel('[DNA] (M)','Fontsize',16);
ylabel('Fluorescence (cps)','Fontsize',16);
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FF.m
function CF = FF(x, xdata)
Dt = 1e-9;
K = x(1);
Fmax = x(2);
Fmin = x(3);
At = xdata;
B = K + Dt + At;
CF = Fmax - ((Fmax - Fmin)./Dt*(B - sqrt(B.^2 - 4.*At.*Dt))./2);
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mci.m
function ci = mci(b,resnorm,J,level)
% Converted from CONFINT Confidence intervals for the coefficients of a fit
result object.
%
calls mtinv, mbetainv, mbetacdf, mbetapdf
%
%
CI = MCI(b,resnorm,J,level) specifies the confidence level.
%
LEVEL must be between 0 and 1, and has a default value of 0.95.
%
%
%
%
%

b
resnorm
J

is the parameters of the fit (xf from lsqcurvefit)
is the sum of the squares of the residuals (sse)
is the jacobian matrix of size [m n]
where m is the number of data points (rows) and
n is the number of parameters (columns)

% Covariance matrix of fitted parameters is
%
V = inv(X'*X) * (sse/dfe)
% and the confidence intervals are
%
b +/- sqrt(diag(V)) * tinv(1-(1-level)/2, dfe)

if nargin<4, level = 0.95; end
if length(level)~=1 | ~isnumeric(level) | level<=0 | level>=1
error('Confidence level must be between 0 and 1.');
end
[m,n] = size(J);
sse = resnorm;
residual
dfe = m-n;

%sum of the squared errors, also called the 2 norm of the
%degrees of freedom

%calculate covariance
[Q R] = qr(J,0);
Rinv = R\eye(size(R));
if dfe<=0
error('Cannot compute confidence intervals if
#observations<=#coefficients.');
end
% X=Q*R, so X'*X = R'*Q'*Q*R = R'*R.
% The inverse is Rinv*Rinv' and the diagonals of that can be
% computed using the sum expression on the following line.
v = sum(Rinv.^2,2) * (sse / dfe);
%b = cat(1,fun.coeffValues{:})';
% b= x;
alpha = (1-level)/2;
%t = -mtinv(alpha,dfe);
t = tinv(alpha,dfe);
%db = NaN*zeros(1,length(activebounds));
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db = t * sqrt(v');
ci = [b-db; b+db];
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5.1.8 smkdfit.m, Ff.m and mci.m to obtain equilibrium constant by competition
method
smkdfit.m
x(1)=6.5e-10
Kor=1.0e-11
Ot =1.0e-9; % Ot = OPERATOR OR3 concentrations
Rt =1.0e-9; % Rt = REPRESSOR SM concentrations
xdata = [0
5
10
20
40
60
80
100
120
140
160
180
200
220
240
260
280
300] * 1e-9;
ydata = [203795
216262
222321
230483
242781
252243
259400
263477
266805
271069
273298
273717
275615
276933
277315
279459
280079
278687];
LB=[];UB=[];
% LB=[1.0e-13 120000 40000];UB=[1.0e-01 130000 63000];
Options= optimset;%('Tolx',1e12,'MaxFunEvals',1e8,'MaxIter',1e8);
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[X,RESNORM,RESIDUAL,EXITFLAG,OUTPUT,LAMBDA,JACOBIAN] =
lsqcurvefit('Ff',x,xdata,ydata,LB,UB,Options)
xdata1 = 0:5e-11:3e-7;
B = Ot+Rt+Kor*(1+(xdata1/x(1)));
% Y1 = X(2) - ((X(2) - X(3))./Dt*(B - sqrt(B.^2 - 4.*xdata1.*Dt))./2);
Y1 = 3.0e5-(6.0e4*(B - sqrt(B.^2 - 4.*Ot.*Rt))/Ot)
plot(xdata,ydata,'o',xdata1,Y1,'linewidth',3);
set(gca,'FontSize',16);
CI = mci(X, RESNORM, JACOBIAN, 0.95);
%title('SM-Cro DNA Binding by competition experiment');
xlabel('[SM-Cro (Mt)] (M)','Fontsize',16);
ylabel('Fluorescence (cps)','Fontsize',16);
%legend('Data','Fit');
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Ff.m
function CF = Ff(x, xdata)
Kor=1.0e-11
Ot =1.0e-9;
Rt =1.0e-9
K = x(1);
Dt = xdata;
B = Ot+Rt+Kor*(1+(Dt/K));
thelta =(B - sqrt (B.^2 - 4.*Ot.*Rt))/(2*Ot);
CF = 3.0e5 + (1.8e5 - 3.0e5)* 1e-9* thelta
%CF = 3.0e5 -(6.0e4*(B - sqrt(B.^2 - 4.*Ot.*Rt))/Ot);
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